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ABSTRACT
The Tier 1 Select Agent, Francisella tularensis causes an acute and fatal disease known as
tularemia. Many studies have devoted enormous efforts to understand how F. tularensis avoids
host defense mechanisms, replicates within an extremely secure immune system, and
eventually causes the deadly disease tularemia. The extremely high virulence of Francisella
depends on its ability to manipulate gene expression according to the surrounding environment.
This process requires the involvement of unique transcriptional regulators. Francisella possesses
very few transcriptional regulators, and a majority of them characterized to-date have been shown
to regulate genes involved in virulence and cellular functions. The role of a transcriptional regulator
of F. tularensis belonging to the AraC/XylS in gene regulation and virulence remains
uncharacterized to-date.

This study characterized the role of AraC in gene regulation,

intramacrophage survival, and virulence of F. tularensis.

In specific aim 1, we generated a deletion mutant (araC) of FTL_0689 gene encoding AraC of F.
tularensis Live Vaccine Strain (LVS), and its transcomplemented strain (araC+paraC).

Characterization of the araC mutant demonstrated that AraC does not regulate genes involved
in arabinose utilization. Genomic organization of the araC gene suggested that it may have a role
in the regulation of a unique multidrug efflux pump (MEP) located downstream of it. Our results
revealed that the phenotype of the araC mutant mirrors that of the emrA1 and the silC mutants,
the components of the MEP. However, these phenotypic similarities are not due to the direct
regulation of MEP genes by AraC. Further characterization revealed that AraC is involved in
providing resistance against oxidative stress.

xv

In specific aim 2, we investigated the role of AraC as a global transcriptional regulator in F.
tularensis LVS strain. We studied gene expression profiles of the wild type F. tularensis LVS
and the araC mutant under normal and oxidative stress conditions. The results revealed that AraC
serves as a transcriptional regulator only when the bacteria are exposed to oxidative stress
conditions. AraC is involved in the regulation of virulence genes encoded on Francisella
Pathogenicity Island, stress response genes, energy production, genes encoding enzymes in the
tricarboxylic acid (TCA) cycle, metabolism and regulatory proteins indicating its role as a global
regulator. The differential expression of these genes also impaired the ability of the araC mutant
to survive in macrophages and attenuated its virulence in mice.

Collectively, this study identified and characterized a novel transcription factor, AraC, required for
adaptation of Francisella to oxidative stress conditions encountered outside or within a host.

xvi

1. INTRODUCTION
1.1. Francisella tularensis
F. tularensis is a Gram-negative bacterium that is extremely infectious and as few as ten
bacteria can cause a deadly zoonotic disease [1, 2]. In 1912, F. tularensis was first discovered
in Tulare County, California as the causative agent of a disease in ground squirrels that
resembled plague [3]. After that, Edward Frances greatly devoted his efforts to studying this
bacterium and discovered that it causes a disease with different clinical manifestations in
human and named that disease “tularemia” [4]. Francisella genus was then named after him
as a reward, and the species tularensis was derived from the Tulare County [5] Francisella
descends from the gamma-subclass of the phylum proteobacteria as classified according to
small subunit RNA sequencing and is the only genus within the Francisellaceae family [6].
The Francisella genus branches out into two species: tularensis and philomiragia, which were
categorized based on their fatty acid and genetic material identity [6, 7]. F. tularensis has been
subdivided into four major subspecies: F. tularensis subsp. tularensis (Type A or also referred
to as Schu S4) and F. tularensis subsp. holarctica (Type B), which are virulent for humans
while the other two subsp., F. tularensis subsp. novicida (referred to in this study as F.
novicida) and F. mediasiatica are known to be avirulent [8]. One more subspecies of F.
tularensis isolated in Japan has been identified and is an F. tularensis subsp. holarctica variant
[9] (Figure 1). Furthermore, molecular studies including Multiple-Locus Variable-number
Tandem Repeat (VNTR) Analysis subdivided Type A strains into two genetically unrelated
clades known as type A1 and type A2 [10, 11], Type B strain into: B1, B2, B3, B4, and B5
[11], and currently, F. tularensis subsp. mediasiatica was also subdivided into three clades:
M1, M2, and M3 [12].

The geographic distribution of F. tularensis differs between Type A and Type B strains
[13]. While Type B is less common in North America and prevalent throughout Europe and
Asia, Type A is confined to North America and was also isolated from Central Europe [11,
13]. In addition, the avirulent strains F. novicida and mediasiatica were isolated in the Great
Salt Lake, Utah from Ogden Bay salt water in 1950 [3] and Central Asia, respectively [14].
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Figure 1. Classification of Francisella.
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1.1.1. Disease transmission
Type A and Type B strains of F. tularensis are highly contagious. They can be acquired
through insect bites, direct contact with diseased animals, ingestion of contaminated food or
water, or by inhaling bioaerosols [3]. A majority of F. tularensis infection around the world is
caused by Type B strains [15, 16]. The high mortality rate in North America as a result of F.
tularensis infection is related to Type A strains, whereas Type B strains are less severe for the
disease across the Northern Hemisphere. This indicates that the natural distribution of Type A
and Type B in addition to the severity of the disease is distinct between the two subspecies of
F. tularensis. However, there is no record of F. tularensis subsp. mediasiatica infection in
humans [3]. In contrast, F. novicida can infrequently cause illness in immunocompromised
humans but is highly lethal for rodents [17]. In addition, preliminary investigations indicate
that the bacterial morphology of this subspecies resembles the pathogenic F. tularensis strain
as they share about 78% to 97% of the genetic material [7]. Nevertheless, it is less virulent,
metabolizes sucrose, and does not show any immunologic reaction when administered into F.
tularensis immunized rabbits [18]. This suggests that F. novicida is an excellent tool for
Francisella and tularemia research [17].

1.1.2. Clinical signs and symptoms
The onset of tularemia is very fast causing flu-like symptoms such as high temperature,
sore throat, headache, chills, and general bodily weakness or discomfort [19]. The severity of
the disease depends on various factors including the route of administration, bacterial dosage,
and infecting Francisella subspecies [20]. Moreover, different portals of entry can show the
different clinical manifestation of tularemia in humans [21, 22]. For instance, direct contact
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with infected animals or transmission through insect bites can ulcerate the target area and result
in glandular and ulceroglandular tularemia, which is the most frequent form of the disease.
This will lead to systemic infection due to bacterial drainage to the nearest lymph node [23].
There is also oculoglandular and oropharyngeal tularemia that are caused by eye infection or
ingestion of contaminated materials, respectively. The most acute form of the disease in
humans is pneumonic tularemia which is induced by bacterial inhalation but fortunately, this
occurs infrequently under natural conditions [23, 24].

1.1.3. Bioweapon potential
The concern of using F. tularensis as a potential bioterrorism weapon has emphasized
the importance of classifying it as a Tier 1 Select Agent by the U. S. CDC. The reason is that
F. tularensis has low infectious dosage, ease of transmission, and the ability to cause high rates
of morbidity and mortality [24]. Presently, vaccines against tularemia are not available [25].
In spite of the development of LVS from a Type B strain in the former Soviet Union, it is not
approved for human immunization in the United States because it is not safe or effective
against respiratory tularemia caused by Type A strains of F. tularensis [25, 26]. The Russian
vaccine strain was used to derive the LVS by several passages on peptone cysteine agar [25].
Although LVS is not used to vaccinate humans, it is being used in research studies for several
reasons. One is that the LVS is safe to handle in biosafety level 2 laboratories. Secondly, it has
both high virulence in mice and the ability to replicate identically to the virulent strains. In
addition to that, the virulence genes in Type A and Type B strains are found to be conserved
in the LVS, which favored using LVS to a large extent in the majority of F. tularensis studies
[27, 28].
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1.2. Intracellular life cycle of F. tularensis
F. tularensis is a non-obligatory intracellular bacterium which can infect different cells
including phagocytes such as monocyte-derived macrophages (MDMs) or polymorphonuclear
leukocytes (PMN) and non-phagocytes such as respiratory epithelium and fibroblasts [28-30].
While macrophages are one of the primary and crucial cells that interact with F. tularensis [23]
and are the focus of most studies, the other cell types that bacteria prefer for infection are due
to unknown reasons [28-30]. The life cycle of F. tularensis, upon its entry into macrophages,
is very distinctive since it prevents phagosome maturation and escapes into the cytosol for
replication [24, 30] (Figure 2).
The innate immune response initially comes into play and activates defense
mechanisms including complement system, antibodies, and host defense peptides (HDPs) once
F. tularensis infection is established [23]. If the bacteria fail to resist any of these mechanisms,
they will be defeated, and the infection will be cleared [31]. However, this is not the case with
F. tularensis. It utilizes several structural adjustments to overcome the innate immune response
and avoid any bacteriolysis that allows immune recognition due to the induction of the
proinflammatory cytokines and, then, activates a robust adaptive immunity [23] (Figure 3).
Phagocytes engulf F. tularensis rapidly, within about an hour of infection [29], by
receptor-mediated phagocytosis and enclose it in a phagosomal compartment containing
antimicrobial compounds required for bacterial degradation [23]. These antimicrobials
generated by the phagocytic cells are as a result of a multi-component assembly of a
membrane-attached enzymatic complex, known as nicotinamide-adenine dinucleotide
phosphate (NADPH) oxidase responsible for turning molecular oxygen into negatively
charged and highly toxic superoxide radicals [32]. Thus, at the time of phagocytosis, NADPH
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oxidase subunits aggregate in the phagosomal vacuole to assemble and produce reactive
oxygen species (ROS) [23], which, however, F. tularensis can resist extremely efficiently [33].
Accordingly, Francisella fights these microbicidal mechanisms by some unique
mechanisms and by the escape into the cytosol [23]. F. tularensis phagocytosis not only
supports bypassing extracellular immune defense factors [23] but also avoids the stimulation
of pro-inflammatory cytokines [29]. In addition, F. tularensis suppresses immune recognition
by stimulating transforming growth factor β (TGF-β), prostaglandin E2, or production of other
anti-inflammatory cytokines via undiscovered mechanisms [29]. When Francisella is in the
cytosol, it undergoes rapid replication in spite of the presence of various immune defense
components such as inflammasome [23].
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Figure 2. Intracellular life cycle of F. tularensis. Francisella is internalized by variousreceptors mediated phagocytosis into a phagosome known as Francisella Containing
Phagosome (FCP). Francisella must evade antimicrobial molecules such as NADPH
oxidase that produce ROS and cause respiratory burst. Francisella then disrupts the
phagosome and escapes into the cytosol to undergo several rounds of multiplications
resulting in host cell death. This will be followed by bacterial release to infect new cells.
Modified from Jones et al., 2012 [23].
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Figure 3. Stimulation of extreme immune response upon failure to defeat F. tularensis
infection. Inhalation of bioaerosoles containing F. tularensis results in bacterial entry into
the lamina propria lining of the lung where antigen presenting cells ingest bacteria and
transfer them into the regional lymph nodes. The bacteria will then be presented to T-cells
that will proliferate and produce Interferon-gamma (IFN-γ) and activate macrophages. If the
immune system fails to clear the bacteria, cytokine storm will be produced and bacterial
infection will end in granuloma formation. Modifed from Murray P. R., 2009 [34].
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1.3. Immunity to Francisella
After Francisella infection was established, anti-Francisella antibodies and other
immunogenic molecules are produced in the host against the bacterial antigen,
lipopolysaccharides (LPS) [35]. Vaccination with LVS also induced the production of potent
serum antibodies: IgM, IgA, and IgG within two weeks and was found to specifically target F.
tularensis LPS [36]. The multispecific IgM antibodies mostly induce the early protection
against F. tularensis LVS infection through the intradermal and intranasal routes [37].
Furthermore, the mucosal IgA was found to be involved in the protection against F. tularensis
LVS as it was isolated from the infected host sera and bronchoalveolar lavage (BAL) [38, 39].
Another indication of the IgA involvement is that vaccination through the intradermal route
did not protect against LVS intranasal challenge whereas using the intranasal route for
vaccination protected against other routes of administration [35, 40, 41]. Unfortunately, human
vaccination with LVS did not produce enough anti-Francisella antibodies that protect against
the virulent Francisella strain. However, vaccination with killed Francisella successfully
induced the production of anti-Francisella antibodies but stimulated weak or no cellular
immunity [36, 42].
Interestingly, using LVS, Schu S4, or monophosphoryl lipid A (MPL) component of
LPS to perform nanoparticles incorporating lysate provides immunity against the LVS
challenge in mice [37]. Not only does the nanoparticles incorporating lysate produce serum
antibodies, but it also stimulates and expands the production of T-cell dependent cytokines
[35]. Francisella, as an intracellular pathogen, avoids detection by antibodies unless
translocated to the extracellular environment where antibodies take place and thus, support the
induction of T-cells response [35]. Consequently, T-cells proliferate and stimulate the
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production of T helper 1 (Th1)-type cytokines particularly the INF-γ [36]. INF-γ is an
important cytokine for T-cells priming to LVS as injecting mice intraperitoneally (IP) with
anti-INF-γ antibodies results in a very high morbidity rate unless the mice were challenged
with the lowest dose of LVS [43]. Furthermore, in vitro stimulation of immunity using T-cells
isolated from mice with INF-γ deficiency does not successfully prevent LVS intramacrophage
replication [43]. Proliferated T-cells also induce the production of tumor necrosis factor-alpha
(TNF-α), which activates responding memory T-cells [44].
The establishment of robust memory T-cells is an essential factor in the protection
against intracellular organisms [45]. After T-cells recognize the antigen presented on the
surface of antigen presenting cells, they proliferate and differentiate into memory T-cells. The
peripheral blood mononuclear cell (PBMCs) post-LVS vaccination contained memory CD4 +
and CD8+ T-cells that induce the production of cytokines IL-17 and IL-22, which are produced
by T helper 17 (Th17) cells, a subset of memory T-cells [46]. The level of pulmonary IL-17 is
very crucial for successful vaccination against the virulent strain Schu S4 [47]. Depleting IL17 with neutralizing antibodies at the time of the secondary challenging has been observed to
increase the bacterial burden in mice lungs [47]. Furthermore, CD4 + and CD8+ T-cell
responders of PBMCs of tularemia patients or after vaccination with LVS exhibited a
phenotype of effector memory T-cells that have the ability to induce cell lysis, target variety
of tissues, and persist in the host sera for up to 25 years after the first establishment of
pneumonic tularemia [36, 45]. Moreover, B-cells were found to contribute to the secondary
infection to F. tularensis as they function similarly to antigen presenting cells as well as
cytokine producing cells [48].
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1.4. Virulence factors
F. tularensis is a firm, long-living organism that has the ability to tolerate low temperatures
and to exist for several weeks in different conditions including wet soil, dried grass, and even
on decomposed dead animals [24]. Francisella is also a non-spore-forming bacteria enveloped
by a thin layer of lipopolysaccharide [24]. At present, the virulence factors of F. tularensis and
the mechanisms that it uses to subvert host’s immune response are not clear [2]. Studies have
shown that although LVS is attenuated for virulence in humans, it still causes extreme illness
in animals and results fatal disease in rodents similar to human infection [26]. LVS can
certainly adjust to intra-phagosomal life [49, 50] in mice macrophages and subsequently cause
structural damages to them [2]. Managing virulence mechanisms in Francisella is not
controlled by a specific protein or system. It is a concurrent activity of various systems that
help Francisella to abolish immune defenses, enter host cells, subvert phagosome
antimicrobials by modifying phagolysosome maturation, escape to the cytosol and replicate
with host recognition avoidance, manipulate cell survival/death, and spread to neighboring
cells for new infection [19]. Some of the currently studied virulence factors are located within
Francisella’s envelope which are comprised of the capsule, LPS, outer and inner membranes
(OM / IM), periplasm, and bacterial secretion systems [19].

1.4.1. Francisella capsule
The production of the capsule by F. tularensis is completely sustained in most of the
biovars [51]. It mostly consists of lipids, around 51%, and the remaining is amino acids and
carbohydrates (35 % and 21% respectively) [52]. The density of the capsule is about 0.02 –
0.04 μm and it is translucent according to Hood et al., who revealed that it has a virulent
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function in F. tularensis [52]. Further studies demonstrated that the capsular materials
composed of polysaccharides that were similar to one of the LPS component (O-antigen) [51]
solely, but no other parts of the LPS, such as 2-keto-3-deoxyoctulsonicacid (KDO) and lipid
A, were found by the mass spectrometry and nuclear magnetic resonance (NMR) analysis [51,
53]. Additionally, the sugar composition of the capsule was found to be distinct among F.
tularensis strains such as Schu S4, whose capsule contains two sugars: mannose and rhamnose;
whereas LVS capsule has three: mannose, glucose, and galactose [53]. Some studies have also
shown that different strains produce various capsular-like molecules either due to the bacterial
growth conditions or the surrounding environment, which could be significant to the virulence
pathway [19]. In addition, LVS capsule production was higher when the bacteria were grown
on Chamberlain’s medium and resulted in a more aggressive bacterial infection in mice upon
intravenous inoculation [54].
In contrast to virulent F. tularensis strains, Schu S4, and LVS, F. novicida neither
produces capsule nor its O-antigen [55, 56]. However, studies have found that F. novicida
posses a locus that is highly identical to that responsible for capsule-like complex (CLC)
glycosylation of F. tularensis [55]. This CLC is an extracellular component that is produced
by F. tularensis during certain growth conditions [53]. This may imply that CLC is a potential
virulence factor of F. novicida [55].
Capsule formation in F. tularensis substantially contributes to F. tularensis evasion of
any intracellular immune responses and in general, any in vivo or in vitro virulence
mechanisms [19]. It can protect Francisella from being opsonized either by complement or
antibodies; however, it is not yet understood if it is essential for serum resistance or contributes
to this mechanism in association with other factors [19]. There were many attempts to design
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the F. tularensis vaccine that targets capsule because of their surface localization [19].
Nevertheless, conflicting results have been observed when Schu S4 or the LVS capsular
proteins are used for intraperitoneal immunization, as Schu S4 did not show any protection in
guinea pigs or in mice [52]. On the contrary, LVS capsular proteins protect mice only against
a homologous challenge; however, it did not protect when challenged with Schu S4
intraperitoneally [51].

1.4.2. Lipopolysaccharide
Another virulence factor that F. tularensis employs for immune evasion is LPS. It
consists of lipid A, the O-antigen, and the middle domain which is made of oligosaccharide
[57]. F. tularensis lipid A differs from the Escherichia coli (E. coli) lipid A in that it is
tetraacylated and has 16-18 extent of carbon [58, 59]; while the latter is hexaacylated with 1214 stretch of carbons [19]. Lipid A can trigger the immune system as most Gram-negative
bacteria can modify it for virulence mechanisms [60]. The polysaccharide repeats of the Oantigen; however, are conserved among the virulent strain Schu S4 and the LVS; but differ
from those of F. novicida as detected by mass spectrometry and NMR analysis [61-64] (Figure
4).
Studies have demonstrated that LPS-targeted vaccines show protection only against
homologous challenge with the same species [65]. For instance, using F. novicida lpxF strain
for immunization protected mice only from wild type F. novicida challenge, but not from
challenge with Schu S4 or subsp. holarctica strains [65]. Interestingly, 60-95% of Francisella
lipid A, unlike that of other Gram-negative bacteria, was found to be missing the core or the
O-antigen domains, and these are known as free lipid A [66-68]. In addition, Francisella can
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control the length of the acyl chains according to the surrounding temperature, and this is an
essential virulence mechanism since infecting mice subcutaneously with F. novicida lpxD1
mutant (LPXD1 is an enzyme that adds carbons to acyl chains) was not virulent [69]. These
LPS alterations are significant for Francisella to lower the chances to be recognized by one of
the host LPS detectors, such as LPS-binding proteins, Lymphocyte antigen 96 (MD-2), or TollLike Receptor 4 (TLR4) [70-72].
Normally, Francisella LPS is insufficient to stimulate B-cells. However, at an extreme
high dose, such as 75 μg, F. novicida LPS can promote murine white blood cells to proliferate
[19]. E. coli LPS, on the other hand, enhances B-cell activation via LPS recognition proteins
[19]. Although Francisella alters LPS and avoids innate immune system detection, the
classical pathway of the complement system is induced by some strains such as LVS [73]. The
C3b subunit of the classical pathway opsonizes F. tularensis and facilitates its internalization
into host cells. However, the bacteria have to avert the genesis of the membrane attack complex
by the complement components [19]. Studies revealed that Schu S4, LVS, and F. novicida are
resistant to complement activation because this process depends on the O-antigen subunit of
LPS [74]. Thus, the studies above suggest that F. tularensis controls the phagocytosis process
due to the presence of the O-antigen subunit in any of the capsule or LPS [19]. Furthermore,
TLR4 was found to be deactivated to a great extent because of LPS alteration and subsequently,
it resulted both in evading the immune system and enhancing the virulence mechanism in
general [19]. Taken together, Francisella depends on the O-antigen, either in LPS or capsule
together with the plasmin, to evade the host’s first line of defense, the complement system.
This, in turn, avoids a robust immune response that would normally be induced via pro-

15

inflammatory release when bacteria are detected and ultimately killed by pathogen-associated
molecular patterns (PAMPs) [23].

16

Figure 4. O-antigen of F. tularensis versus F. novicida: The O-antigen repeating molecule
of F. tularensis subsp. tularensis is distinct from that of the F. novicida.
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1.4.3. Type IV pili
Most of the Gram-negative organisms possess Type IV pili which act as an essential
virulence factor as it helps in the attachment to the host cell, gives the bacteria a special
movement technique known as twitching motility, helps bacterial assembly and DNA
acquisition [75, 76]. In F. tularensis, studies have demonstrated that growth conditions can
modify the shape of Type IV pili; for instance, culturing LVS on agar produces horn-like Type
IV pili while growing LVS on broth produces elongated cylindrical fiber-like Type IV pili
[77]. The Type IV pili are observed on F. tularensis Schu S4 and F. novicida [78, 79]. Some
studies, on the other hand, reported that no pili are detected neither on subsp. holarctica strain
nor F. novicida, suggesting that the presence of pili depends either on Francisella strain or on
growth conditions among different laboratories [80, 81].
The pilus is composed of five or six pilin subunits; from PilE1 to PilE6 [77, 79].
Genomic sequencing of F. tularensis indicated that Schu S4 and F. novicida have the six
subunits while Type B strain has many mutations or deletions in pilE1, pilE2, or pilE3 [79].
LVS, on the other hand, has pilE1 deleted and pilE2 and pilE3 containing premature stop
codons [77]. In particular, PilE1 was found to be playing an important role in Francisella
virulence. During infection, LVS forms several glycosylated multimers of PilE1 on its surface.
It is this glycosylation of Type IV pili that makes it infectious [80]. Previous reports on mice
subcutaneously infected with either Schu S4 or Type B strain was also found to have the
virulence factor PilE1 and was determined to be responsible for the entire virulence
mechanisms of these strains [80, 82]. Furthermore, Salomonsson et al., reported that transcomplementation of pilE1, along with or without other genes in LVS, makes the bacteria highly
virulent [83]. Studies also noted that the proteins which are important for Type IV pili assembly
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in Francisella play an important role in the virulence [19]. Thus, like other Gram-negative
bacteria, Francisella expresses Type IV pili that enhance bacterial virulence and intracellular
survival.

1.4.4. Francisella secretion systems
Most Gram-negative bacteria have Type I secretion system that facilitates toxins and
drugs transport and thereby assists in the virulence mechanisms [84-86]. Three ortholog genes
of the outer membrane, tolC, of E. coli and other bacteria were detected in F. tularensis by the
genomic and bioinformatic analysis. These genes are tolC, ftlC, and silC with the locus tags
FTL_1865, FTL_1107, and FTL_0686, respectively [87], and are found to be essential for LVS
resistance to antimicrobial drugs, dyes, and detergents [87, 88]. The structure of Type I
secretion system is characterized by the association between three subunits: the OM TolC, an
IM ATPase, and a transmembrane protein, forming a three-component system [89]. In a study
using Schu S4 tolC mutants, it was found that they were partially attenuated following
intradermal mice infection as mice survived two more days as compared with those which
received wild type bacteria [90]. LVS tolC mutants were unable to survive and therefore could
not spread within the host cells, leading to conditions which were permissive for the proinflammatory cytokines cascade, which in combination, led to macrophage death. This
suggests that TolC might be contributing to other unknown virulence pathways [91, 92].
Another protein on F. tularensis OM, SilC, identical to silver cation efflux proteins, has some
sequence similarity with TolC and FtlC [93]. A study conducted from our lab has characterized
the role of SilC in F.tualrensis LVS and demonstrated that this OM protein is involved in the
resistance to antibiotics, oxidants, and silver. In addition, SilC is also crucial for F. tularensis
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virulence in vivo and in vitro [87]. Another study on OM orthologs of Schu S4 showed that
TolC was required for in vivo virulence when bacteria were administered intranasally and
intradermally. However, FtlC was required for virulence using the intradermal route of
administration, indicating that F. tularensis virulence is dependent on the route of entry to the
host [94].
Gram-negative bacteria also have Type III and Type IV secretion systems that are
essential for the bacterial virulence mechanism and are characterized by infusing effector
proteins through the plasma or internal membranes [95-97]. F. tularensis, especially Schu S4,
lacks any of Type III or Type IV secretion system orthologs or functional proteins [98].
Although studies have identified some of the virulent genes that share homology with Type III
and Type IV secretion systems in F. tularensis subsp. mediasiatica, these genes are determined
to be non-functional in Francisella species. To date, no intact or functional Type III or Type
IV secretion systems have been detected in Francisella except Type IV pili biogenesis system
that has some subunits shared with Type III secretion system while the majority of other
subunits are homologous to components of Type II secretion system [88, 99, 100].
Additionally, studies on F. novicida indicated that Francisella pathogenicity island
(FPI) encodes Type VI secretion system [101, 102], which is described by infusing the effector
proteins into host cells or other bacterial cells in a similar manner to the T4 bacteriophage
injecting mechanism [103, 104]. Two proteins, IglA and IglB, compose the outer sheath of
Type VI secretion system and are found to be arranged together when the bacteria are under
stress, such as during phagocytosis, an alkaline environment (5% KCl), and oxygen availability
[105], suggesting that Type VI secretion system might be important for Francisella virulence.
Other important subunits, such as DotU and VgrG, also promote phagocytosis resistance and
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virulence during intradermal or intranasal mice infection [101, 106]. Moreover, LVS uses Type
VI secretion system to secrete IglC, IglE, IglF, IglI, IglJ, PdpA, PdpE, and VgrG effector
proteins into host macrophages, while IglC, IglE, PdpA, and PdpE proteins are secreted by F.
novicida, suggesting that every species has its specific Type VI secretion effector proteins
[107]. Type VI secretion system effector proteins are not fully characterized despite the
involvement of this secretion system in the virulence of F. novicida in a mouse model [7].

1.5. The Multidrug efflux pump (MEP) system
F. tularensis have evolved other mechanisms to avoid or counter the host immune
system [23]. These mechanisms depend on the nature of the host defenses that the bacteria
encounter. For example, when F. tularensis confront host defense peptides, it can repulse the
interaction between them and avoid their antimicrobial effect by managing its surface charge
as these peptides are usually positively charged [23]. However, some antimicrobial peptides
have no surface charge or can bear the same charge as the bacteria, which makes it difficult for
F. tularensis to resist them by modifying its surface charge. Thus, F. tularensis uses another
strategy that employs the MEP system to help diffusing antimicrobial drugs out of the
bacterium [23].
F. tularensis subverts host defensins and other microbicidal components by encoding
one or more of the MEPs similar to other bacteria including Neisseria, [108], Pseudomonas
[109], and Salmonella [110]. One of the most commonly studied MEP systems in F. tularensis
is known as the AcrAB/TolC efflux pump [23]. The MEP is composed of IM AcrAB [111]
and OM TolC components [88, 91]. The importance of this system, specifically TolC subunit,
is due to its activity toward antibiotics such as ß-lactam, tetracycline, aminoglycoside, and
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quinolone and also toward detergents including bile salts and dyes effective against Gramnegative bacteria [88, 91, 111]. In vivo studies have shown that disrupting the MEP subunits
leads to attenuation of virulence in mice [88, 91, 111].
There are two categories of the MEP: the ATP-binding cassette (also known as ABC)
transporters and the secondary transporters [112]. The fuel for ABC transporter depends on
Adenosine triphosphate (ATP) while the secondary transporters depend on either sodium or
protons electron gradients [112]. Furthermore, the secondary transporters are further
subcategorized into four super-families according to their compositional similarities [84].
These four subcategories are: major facilitator superfamily (MFS), resistance nodulation
division (RND) family, multidrug and toxic compounds extrusion (MATE) family, and small
multidrug resistance (SMR) family [84] (Figure 5). While the RND superfamily is specific for
most Gram-negative organisms, the other efflux pumps can be found in any of Gram-positive
or negative organisms [113].
Studies have found that 31 MFS transporters are encoded by F. tularensis genome
[112] and the virulent strain Schu S4 has 15 active ABC transporters that are detected in silico
[114]. In a study of LVS multidrug transporter, AcrAB RND, the AcrB subunit was categorized
as an important virulence factor in mice along with its essential role in antibiotics and
antimicrobial peptides avoidance [111]. However, another study using Schu S4 subspecies
demonstrated that not only AcrB is required for drug resistance, AcrA also plays an important
role in the efflux of dyes and detergents but not for virulence in mice [115].
Interestingly, an additional role of the multidrug efflux pump is the involvement in
resisting the oxidative stress mechanism [116-118]. Ma et al., (2014) reported that EmrA1 of
F. tularensis LVS contributes to virulence in mice as it influences the production of the
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antioxidant enzymes, SodB and KatG, that are required for resisting oxidative stress and thus,
intramacrophage survival. [112]. acrB and tolC mutants, however, secreted SodB or KatG
enzymes as detected in the culture filtrate and also did not show any susceptibility towards
oxidants, yet, only sensitive to detergents and dyes [88, 111, 115].
The AcrAB/TolC efflux pump is regulated by the AcrR transcriptional regulator (a
repressor) [113], which is a member of the TrtR family transcriptional regulators present in
most bacteria that contain helix-turn-helix (HTH) domain specific for DNA binding [119].
This DNA binding motif is substantially conserved in most of TrtR family members [119]. In
addition, proteins encoded by members of TrtR family regulate several genes that are required
for resisting multidrugs and osmotic shock, catabolic enzymes, antibiotics biosynthesis, and
virulence of most bacteria [119]. Hence, TrtR family members are essential for bacterial
adjustment to various surrounding conditions [119]. Furthermore, AcrAB efflux pump was
found to be activated by members of the AraC/XylS family; MarA, SoxS, and Rob [120-122].
However, they are not required for regulating the efflux in response to bacteria stress [123128]. Studies suggested that during stress, the expression of acrAB is regulated by a unique
mar-sox pathway that is independent of AcrR [119].
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Figure 5. Superfamilies of bacterial efflux pumps and their substrates. Modified from
Piddock, 2016 [129].
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1.5.1. F. tularensis transcriptional regulators
Francisella possesses very few transcription regulators. A majority of these has been
shown to regulate genes involved in virulence [130]. In general, bacteria produce transcription
factors that bind to either specific or nonspecific DNA domains. The determination of whether
the transcription factor is a repressor or activator depends on where the binding domain is
located and on its sequence contents [130]. Transcriptional regulators are affected by several
environmental factors such as high or low temperature, iron availability, oxidative pressure,
and other antimicrobial compounds within macrophages. However, the molecular pathway
behind the regulation needs further studies [130].
Three transcriptional regulators regulate FPI: MglA (macrophage growth locus protein
A), SspA (stringent starvation protein A), and PigR (pathogenicity island gene regulator) [131,
132]. MglA and SspA are members of SspA family, and they function as a heterodimer that
attaches to RNA polymerase (RNAP) [131, 133, 134] to regulate expression of virulent genes
[135]. The SspA-MglA complex was also found to be involved in the bacterial response to
stringent amino acid starvation leading to alarmone release, which is a guanosinepentaphosphate ((p)ppGpp) [136]. PigR, or FevR (Francisella effector of virulence regulation)
[130] in F. novicida, is a DNA binding protein that is recruited to the SspA-MglA-RNAP
complex [132, 137]. It associates with the SspA and MglA to upregulate expression of other
virulence genes that are not in the FPI [135]. In addition, about 100 genes that might be virulent
were found to be regulated by SspA-MglA-PigR [136, 138]. fevR/pigR are positively regulated
by MigR (macrophage intracellular growth regulator or also known as CaiC) to manipulate
FPI gene expression. As most transcriptional regulators have DNA binding domain [139],
MigR lacks this domain but still regulates the transcription of fevR/ pigR indirectly by
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interacting with either of two genes: RelA or SpoT (stringent response regulators), which leads
to the production of alarmone and thus controls fevR expression for virulence mechanism
[130].
Studies have shown that response to the stringent starvation is not only exclusive to the
binding of PigR to the complex, another transcriptional regulator, known as PmrA, was also
found to be involved. PmrA is a DNA binding protein too that is homologous to that in
Salmonella spp. where it functions as a response regulator of the two-component system (TCS)
[140]. It is phosphorylated by the histidine kinase KdpD at the PhoP phosphorylation site
(Asp51) [141] to form a member of the orphaned TCS in F. tularensis [130]. Another member
of the TCS in F. tularensis is QseC that contributes to the virulence mechanism and regulation
[140, 142]. Therefore, F. tularensis activates the TCS (PmrA and KdpD) leading to the binding
of PmrA to promoters and then to the MglA-SspA-RNAP complex or freeing RNAP to
regulate virulence gene transcription [143].
Besides the above-mentioned transcriptional regulators, iron limitation causes stress on
F. tularensis that requires the presence of specialized ferrous transcriptional regulator to
manipulate iron gene expression. Fur is a ferric uptake regulator that binds to ferrous iron,
when available, to downregulate iron genes [130]. These genes are upregulated by Fur in case
of the iron-limiting environment [130]. They are located downstream of fur in F. tularensis
and are known as F. tularensis siderophore locus (fsl) or F. tularensis iron genes (fig) [144,
145].
In addition to iron availability, temperature fluctuation during Francisella infection is
another environmental stress. Before entering warm-blooded hosts (37°C), Francisella can
survive in a 25°C environmental temperature and subsequently requires to adapt by modifying
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the Lipid A composition of its LPS [146]. Studies demonstrate that F. tularensis has only two
sigma factors (the housekeeping σ70 and the stress-related σ32), unlike E. coli and Bacillus
subtilis that have six to eight sigma factors [130]. σ32 in F. tularensis is known as RpoH and is
responsible for inducing the heat shock proteins [147-149]. Interestingly, several heat shock
and virulence proteins of F. tularensis LVS are induced when exposed to higher temperatures
[130]. Nevertheless, only 13 of the upregulated genes have a promoter binding site for σ 32, and
none of these genes is located in the FPI [149]. This indicates that there is an indirect path of
σ32 to regulate virulence genes [130].
Another crucial transcriptional regulator in F. tularensis that is involved in the
oxidative stress resistance is known as OxyR, which is a member of LysR transcriptional
regulator family [150]. Like most of transcriptional regulators, members of this family has an
HTH motif in the N-terminal and a regulatory domain in the C-terminal [150]. In several
bacteria, the regulation of oxidative stress is manipulated by many regulators including OxyR,
SoxR, PerR, and RNA polymerase of stationary phase (RpoS) [151]. Other regulators that act
on resisting oxidative stresses, especially to reduce the effect of RNS and iron-sulfur
development, include NorR and IscR [152]. E. coli overcomes hydrogen peroxide (H2O2)
toxicity, heat shock, oxidative stress, and death by phagocytosis by regulating essential genes
using the transcriptional regulator OxyR [153]. This requires oxidation of Cys199 and Cys208,
conserved loci, as a result of H2O2 stimuli [154]. SoxR, on the other hand, is involved in
resistance of superoxide radicals, nitric oxide (NO), or H2O2 at higher concentrations [155]. F.
tularensis, as revealed from sequencing, has OxyR and RpoS homologs only when it lacks
SoxR/SoxS regulators [98]. OxyR in F. tularensis plays a central role in regulating the genes
that are essential for ROS and oxidative stress resistance as well as bacterial survival and the
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virulence mechanisms in vivo [156]. OxyR binds directly to the promoter regions of
antioxidant enzyme genes alkyl hydroperoxidase (ahpC) and catalase (katG) to regulate their
expression [156].
Additionally, by analyzing the genome of F. tularensis, we have identified a novel
transcriptional regulator that is homologous to AraC regulators present in other Gram-negative
bacteria. The AraC regulator belongs to the commonly known positive transcriptional
regulators, the AraC/XylS family. They are characterized by the presence of high sequence
similarity of amino acids that are expanding for a length of 100-residues to form two HTH
DNA binding motif. This motif is unique and conserved among AraC/XylS family members.
The first detected and biochemically studied AraC transcriptional regulator is the one that
controls L-arabinose operon in E. coli. It functions as an activator of the araBAD operon as
well as others, araFGH and araE [139], to manipulate L-arabinose utilization and catabolism
[157] (Figure 6).
AraC regulator has also been identified in Erwinia chrysanthemum, Citrobacter
freundii, and Salmonella and functions similarly to that of the E. coli. Members of the
AraC/XylS family are involved in the regulation of several mechanisms in bacteria. Some of
them control the metabolic functions of specific elements including carbon, amino acids,
alcohol, and herbicides. Others are responsible for regulating the secretion of virulence
proteins such as siderophores, urease, and those required for attachment to epithelial cells,
composing cellular capsule, or invasion. Some members of the AraC/XylS family also play a
central role in regulating bacterial response to alkylating agents, oxidative stress, antibiotics,
and other stress environments [139]. Nonetheless, the role of AraC regulator in F. tularensis
is not known yet.
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Figure 6. Schematic diagram of transcriptional regulation of L-arabinose operon by
AraC in E. coli. (a) AraC monomer structure. (b) When arabinose is absent, two AraC
monomers bind to I1 and O2 causing DNA to bend and form a loop that halks transcription
of araBAD by RNA polymerase. (c) When arabinose is available, allosteric changes will
occur in AraC dimer resulting in the release of the O2 site and binding of the dimer to I1 and
I2 .This will facilitate RNA polymerase transcription of araBAD. Modified from Yang et
al., 2011 [158].
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2. HYPOTHESIS AND SPECIFIC AIMS
Several studies have devoted enormous efforts to understand how F. tularensis avoids host
defense mechanisms, replicates within an extremely secure immune system, and eventually
causes the deadly disease tularemia. The extremely high virulence of Francisella depends on
its ability to manipulate gene expression according to the surrounding environment. This process
requires the involvement of unique transcriptional regulators. Francisella possesses very few
transcriptional regulators, and a majority of them characterized to date has been shown to regulate
genes involved in virulence and cellular functions. The role of a transcriptional regulator of F.
tularensis belonging to the AraC/XylS in gene regulation and virulence remains uncharacterized
to date.

The goal of this study was to characterize the role of AraC as a transcriptional regulator in F.
tularensis. Previous studies focused on understanding the role of AraC transcriptional regulator
in E. coli reported that araC encodes a protein that is required for regulating arabinose
utilization genes [130-134]. Other studies, on the other hand, found that members of the AraC
family of transcriptional regulators are involved in regulating virulence-associated genes.
[110]. This study aimed at characterizing the novel role of AraC as a transcriptional regulator
in F. tularensis. In several Gram-negative bacteria, araC is transcribed divergently from and
controls araBAD operon. While in F. tularensis, it is transcribed divergently from an operon
encoding EmrA MEP. Thus, the overall hypothesis set forth was: “AraC may have a unique
role in transcriptional regulation of multidrug efflux pump genes in addition to the genes
involved in general metabolism as well as the stress response.” The following specific aims
were proposed to address this hypothesis:
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Specific Aim 1: Phenotypic characterization of the araC gene deletion mutant (ΔaraC) of
F. tularensis LVS. AraC transcriptional regulator is known in most Gram-negative bacteria
for its role in regulating the araBAD operon. Because the role of araC in F. tularensis has not
been defined, in this study several potential functions of araC were to be examined to
determine the exact role of this gene. A clean gene deletion mutant (ΔaraC) and the
transcomplemented strain (ΔaraC+paraC) of F. tularensis LVS were generated and
characterized for the role of AraC in 1) sugar utilization and metabolism; and 2) resistance to
oxidative stress and antibiotics due to its proximity to the genes encoding Emr MEP.
Specific Aim 2: Investigation of the role of AraC as a global transcriptional regulator in
F. tularensis LVS. The role of AraC as a transcriptional regulator in F. tularensis was
determined by 1) deep RNA sequencing analysis to obtain a signature expression profile of
genes in ΔaraC mutant in presence or absence of oxidative stress; 2) confirmation of
differentially expressed genes by quantitative real-time PCR; and 3) establishing the role of
AraC in transcriptional regulation of differentially expressed genes in intramacrophage
survival and virulence in mice.
The results from these studies were expected to provide comprehensive information regarding
the genes that were under the control of AraC in absence or presence of oxidative stress. It was
also our expectation that these studies would uncover the role of AraC in transcriptional
regulatory mechanisms of F. tularensis.
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3. MATERIALS AND METHODS
3.1. Bacterial strains
The bacterial strains used in this study are listed in Table 1. The wild type F. tularensis
LVS used in this study was obtained from BEI Resources, Manassas, VA. The deletion mutant
of araC (FTL_0685) gene (ΔaraC) of F. tularensis LVS and its transcomplemented strain
(ΔaraC+paraC) were generated in Dr. Meenakshi Malik’s laboratory at Albany College of
Pharmacy and Health Sciences (ACHPS), Albany, NY. A transposon insertion mutant in
emrA1 gene of F. tularensis LVS available in our laboratory and used in previously published
works was also used in this study. The E. coli DH-5α and S17 strains were obtained from
Invitrogen.
The Francisella strains were cultured on Mueller-Hinton (MH) chocolate agar plates
(BD Life Sciences) and incubated for 48 hours at 37οC and 5% CO2. Individual colonies were
selected and inoculated at MH broth (MHB) enhanced with Isovitalex (BD Biosciences, San
Jose, CA), Ferric Pyrophosphate, Glucose, Anhydrous Calcium Chloride, and Hydrous
Magnesium Chloride. The bacterial cultures were incubated at 37 οC with constant shaking
until the bacterial growth reached the mid-log-phase. Bacterial aliquots were snap-frozen in
liquid nitrogen and stored at -80οC. The emrA1 mutant was grown on MH Chocolate agar
plates, or MHB supplemented with Kanamycin (10µg/ml). For the transcomplemented strain
(ΔaraC+paraC), Hygromycin (100µg/ml) was added to the media instead of Kanamycin. All
work was performed under containment of Biosafety level 2 (BSL2).
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Table 1. List of bacterial strains, plasmids, and primers used in this study

Strains, plasmids, and
primers

Description

Source or
reference

Strains
F. tularensis LVS
F. tularensis ΔaraC
mutant

Wild type strain
Deletion mutant of araC gene of F. tularensis LVS

F. tularensis emrA1
mutant
F. tularensis araC
transcomplemented
strain (ΔaraC+paraC)
E. coli

LVS FTL_0687::Tn5 Kanr

Plasmids
pMP822
pJC84
pMM03
pMM014
Primers for araC gene
deletion
MP135

MP137

MP139

MP140

Primers for confirmation
of araC gene deletion
MP037

F. tularensis LVS, ΔaraC, pMM09
(pMP822+araC), Hygror
F–Φ80lacZΔM15Δ(lacZYA-argF) U169 recA1
endA1 hsdR17 (rK–, mK+) phoA supE44 λ– thi-1
gyrA96 relA1

E. coli-Francisella shuttle vector, Hygror
E. coli-Francisella suicide vector, Kanr
pJC84 + fused flanking fragment of araC gene, Kanr
pMP822 + araC, Hygror

5’CAAGGATCCAAATAGATTGTGTTAGCATTGC
AC-3’
5’TTTATCTGTACTCTTTCACTAGAGCATACTTT
GTCCTTTTTTCACCA-3’
5’TGGTGAAAAAAGGACAAAGTATGCTCTAGT
GAAAGAGTACAGATAAA-3’
5’TGATGTCGACGCAATACTCAAGTGGAACAAC
TGG-3’

5’CCGGATCCATGAAATTTGAATTACCAAAAC3’
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ATCC
This study
(Dr. Malik’s
Lab.)
[112]
This study
(Dr. Malik’s
Lab.)
Invitrogen

[159]
[160]
This study
This study

MP 038

5’CGCTGCAGCTAATCAGCGAATTGCTCAGAAA
C-3’
5’-ATGGGTGTTGCCATCAAATAGG-3’
5’-TGTTGTCGCCAACGTGAAA-3’

MP192
MP193
Primers for
transcomplementation
MP372

MP373

Primers for qRT-PCR
SilC
MP015
MP016

5’CAAGGTTCCATGATACGGGAAGAGATCACA
TAT-3’
5’TGATCTCGAGTCAGTTCTTATAAATATTTTTT
ATC-3’

5’-AAGCCAAGTTAGTGCTGCATATTT-3’
5’-AAGCCAAGTTAGTGCTGCATATTT-3’

emrA1

MP017
MP018

5'-GTGCATCTTGTAAAGAGCCAGCATC-3'
5'-CAGCCAAACTAAGCGCACAGTCAT-3'

emrB

MP019
MP020

5’-TCCTAATCCCTGAATAGCCGTTGT-3’
5’-AGGTGTTGCCGCTATTATTGGTGC-3’

groES

MP280
MP281

5’-ACCCATGATATCTTCTTCTCTC-3’
5’-AGAGTATTAGTTCGTCGTGCAG-3’

groEL

MP282
MP283

5’-TCTTCAAAGCCTTTGCCTTC-3’
5’-TGTCACTGCAGGTATGAATCC-3’

ClpB

MP284
MP285

5’-TTTCATAATCCTGACCTTGCA-3’
5’-GGCGGCTATCTAACTGAACAT-3’

FTL_1957

MP286
MP287

5’-AGATATAACAGAAGATGAAGCTGC-3’
5’-TAGGGATGTTCAAGCTTAGTAC-3’

dnaJ

MP564
MP565

5’- GCCAAGGTACTATTCGTAGACAAC -3’
5’- ATTAGAGCCAGAATCACCCTCA -3’

dnaK

MP562
MP563

5'-TAGTGGGTGGACAAACTCGTATG-3'
5'-TCTCAATACCTAGAGAAAGCGGTG-3'
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3.2.

Construction of ΔaraC gene deletion mutant of F. tularensis LVS
The plasmids and primer sequences used for generation and confirmation of the

deletion mutant of F. tularensis araC gene and the transcomplemented strain are listed in
Table 1. pJC84 suicide vector that allows for SacB-dependent allele replacement was used as
reported earlier [160] for the generation of in-frame gene deletion of araC gene (FTL_0689)
in F. tularensis LVS. For deletion of araC gene, a 5’ fragment composed of a 1152bp sequence
from upstream to the start codon of FTL_0689 to the start codon was amplified by PCR using
MP135 and MP137 primers. In addition, a 3’ fragment of a 2081bp from downstream of
FTL_0689 to the stop codon was also amplified by PCR using MP139 and MP140 primers. By
overlapping extension PCR using Pfx enzyme with primers MP135 and MP140, both
fragments were merged to generate a larger fragment (2233bp). Since MP135 contained a
BamH1 site and MP140 with a SalI site, the merged fragment was cloned into the BamH1 and
SalI sites of pJC84 to generate pMM03. After that, PCR confirmation is performed. For
electroporation, F. tularensis LVS were cultured in MH-chocolate agar plate for 48 hours at
37οC with 5% CO2. A starting OD600 of 0.05 F. tularensis LVS colonies was prepared in a 30
ml MHB and incubated at 37οC with shaking. Once the suspension reached an OD600 of
approximately 0.5, the bacteria were centrifuged at 4οC for 5 minutes at 4000 g. Then, the
supernatant was discarded; the pellet was resuspended in the same volume of 0.5M sucrose
solution for washing and then resuspended in 100µl of 0.5M sucrose solution. After that, 1µg
of pMM03 was added to the bacterial suspension and incubated on ice for 10 minutes.
Electroporation was conducted using an Eppendorf Eporator at 2,500 V, 200Ω, 25µF.
Immediately after electroporation, 1ml of pre-warmed MHB was added and bacteria were
incubated for another 2-3 hours at 37 οC with agitation. Then, the electroporated bacteria were
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centrifuged at 4οC for 5 minutes at 4000 g and resuspended in 100µl of 0.2M KCL. The bacteria
were selected for antibiotic resistance on MH-chocolate agar plates containing 25µg/ml
kanamycin. Following that, sucrose counterselection was performed by growing 0.5 OD 600 of
independent kanamycin resistant clones on MHB at 37 οC with shaking and then supplemented
with sucrose solution to make a final concentration of 5% and incubated for additional 2 hours.
After incubation, the bacteria were serially diluted and plated on MH-chocolate agar
supplemented with 8% sucrose and incubated at 37οC with 5% CO2 for 48 to 72 hours. To
verify loss of Kanamycin resistance marker, sucrose resistant clones were streaked into MHchocolate agar plates containing 25µg/ml Kanamycin. The sucrose resistant and Kanamycin
sensitive clones were screened for the loss of araC gene using PCR. For araC gene deletion
confirmation, a duplex colony PCR was performed using the primer sets: araC gene specific
(MP192/MP193) and internal control-sodB gene (MP037/MP038) (Figure 7). To confirm the
in-frame FTL_0689 deletion, we conducted genomic DNA sequencing for PCR positive
clones.
For the transcomplemented strain (ΔaraC+paraC), the sequence of F. tularensis araC
gene was amplified using the primers MP372 and MP373 with the enzyme Pfx. BamHI and
XhoI restriction enzymes were used to digest the amplified sequence and then cloned into
E.coli-Francisella shuttle vector pMP822 [159] to generate pMM014. This plasmid was then
confirmed using PCR and DNA sequencing and was electroporated into ΔaraC mutant at 2,500
V, 200Ω, 25µF. To confirm the transcomplementation of araC gene, the bacteria were selected
in MH-chocolate agar plates containing 200µg/ml hygromycin. The hygromycin-resistant
colonies were screened later with PCR.
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Figure 7. The genomic organization of the araC gene (FTL_0689) of F. tularensis LVS.
The gene presents upstream of the three MEP genes emrB, emrA1, and silC. The grey arrows
represent the location of the primers used to screen araC gene deletion.
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3.3. Determination of the role of AraC in sugar utilization
The AraC of F. tularensis LVS was evaluated for its role in arabinose sugar utilization.
Two different experiments were approached by growing the bacteria on MH chocolate agar
plates with or without the sugars and by generating growth curves in the presence or absence
of sugars.

3.3.1. Growth in arabinose versus glucose containing chocolate agar
Mueller Hinton (MH)-chocolate agar plates containing glucose or arabinose sugars
were prepared in our lab. Wild type F. tularensis LVS or ΔaraC mutant were grown overnight
in MHB at 37οC with shaking. Bacteria were washed twice using 1×Phosphate-Buffered Saline
(PBS) to remove any excess growth media. E. coli DH-5α or E. coli S17 used as positive
controls. Bacteria were streaked on MH chocolate agar plates supplemented with 1% glucose
or 1% arabinose and incubated 37οC with 5% CO2 for 48 hours. The bacterial growth pattern
of ΔaraC mutant was compared to that of the controls.

3.3.2. Bacterial growth curve using Chamberlain’s Defined medium (CDM)
A chemically defined medium known as Chamberlain’s medium was prepared as
described previously [161]. The sugar concentration in the CDM was 0.4% and the media were
prepared at three different conditions: 1) +glucose/-arabinose, 2) -glucose/+arabinose, and 3)
-glucose/-arabinose. F. tularensis LVS or the ΔaraC mutant were cultured at 37οC with 5%
CO2 for 48 hours and washed twice with 1× PBS before inoculated into CDM. Bacteria at 0.2
OD600, which corresponded to 1×109 CFU/ml, were inoculated into the CDM and incubated at
37οC with shaking. OD600 was recorded every 4 hours, and growth curves were generated using
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GraphPad Prism 6 software.

3.4. Disc diffusion assays
Disc diffusion assay, also known as Kirby-Bauer assay for antibiotic sensitivity testing,
is a technique using sterile paper discs containing antibiotic or any other compound to
determine bacterial sensitivity to that specific antibiotic/compound. F. tularensis LVS or the
∆araC mutant was grown on MH-chocolate agar plate and incubated for 48 hours at 37 οC and
5% CO2. The bacterial suspension was prepared using sterile 1× PBS and adjusted to 2.0 OD 600.
A thick bacterial layer was spread on MH chocolate agar using sterile cotton swabs (Puritan
Medical Products Company, Guilford, Maine). Antimicrobial susceptibility test discs
including: Polymyxin B (300IU/IE/UI), Nalidixic acid (30µg), Chloramphenicol (30µg),
Streptomycin (10µg), Erythromycin (15µg), Gentamycin (10µg), Novobiocin (30 µg), or
Tetracycline (30µg) (BD BBL™ Sensi-Disc™) were placed over the bacterial lawn and
incubated at 37 ºC and 5% CO2 for 48 hours or until bacterial lawn was thick enough to observe
antibiotic sensitivity indicated by a zone of clearance around the disc. Using a ruler, the
bacterial sensitivity was determined by measuring the zone of inhibition around antibiotic discs
(in mm). If the bacterial susceptibility to a certain antibiotic is more, a larger zone of inhibition
is formed around that antibiotic disc.

3.5. Determination of the sensitivity of F. tularensis ΔaraC mutant to oxidants
The sensitivity of the ΔaraC mutant to various oxidants was determined using bacterial
killing assay and by generating bacterial growth curves as described above. The bacterial
growth curve used for bacterial sensitivity was generated using MH-broth, instead of CDM.
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3.5.1. Bacterial killing assay
The bacterial killing assay is a direct method to determine the sensitivity of the bacteria
to certain oxidative compounds. The procedure was performed according to the previously
published protocols from our lab [112, 162, 163]. In brief, peroxides [1mM H 2O2, tert-butyl
hydroquinone (TBH) and cumene hydroperoxide (CHP)] or superoxide-generating compounds
(20 mg/ml menadione, 50 mg/ml pyrogallol, 50 mg/ml paraquat) were serially diluted in a 96
well-plate using MHB or 70% ethanol in case of CHP and paraquat. Wild type F. tularensis
LVS or the ΔaraC mutant was adjusted to 0.2 OD600, and an equal amount of bacteria were
added to each well containing the serially diluted compounds. The 96 well-plate was incubated
for 1 and 3 hours at 37οC and 5% CO2 and then the bacteria were spotted on MH-chocolate
agar plates using a multichannel pipette. In another approach, bacterial suspensions were
exposed to H2O2, pyrogallol, or paraquat for 1 hour with shaking at 180 rpm and 37 οC. Bacteria
were serially diluted (10-fold) and plated on MH chocolate agar for 48 hours at 37 οC and 5%
CO2. Colony forming units (CFUs) of bacteria were counted and plotted as Log10 CFU/ml.

3.5.2. Cell culture assay
Murine Raw 264.7 macrophage cells (1x106 cells/well) were seeded in a 24-well tissue
culture plate. Dulbecco's Modified Eagle's medium (DMEM) (Corning, without L-glutamine
and Sodium Pyruvate) was used in this experiment and was supplemented with 10% heatinactivated Fetal Bovine Serum (FBS), 2% L-glutamine, and 1% Sodium Pyruvate. The cells
were infected with F. tularensis LVS or the ΔaraC mutant at a multiplicity of infection (MOI)
of 1, 10, 100, or 500. Cells were centrifuged for 10 minutes at 1000 rpm to synchronize
bacterial infection and incubated at 37οC and 5% CO2 for 4 and 24 hours. Two hours post-
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infection, medium from the infected cells was replaced with DMEM containing gentamycin
(250µg/ml) to kill extracellular bacteria and was replaced with DMEM without any antibiotics
after one hour of incubation. The cells were lysed with 0.1% sodium deoxycholate at 4 and 24
hrs post-infection and then (10µl) of 10-fold serial dilution of the lysed cells was spotted on
MH chocolate agar plates for enumeration of bacterial CFUs. Plates were incubated at 37 οC
and 5% CO2 for 48 hours and figure was generated using GraphPad Prism 6 software (Figure
8).

3.6. Mouse survival studies
The role of AraC in virulence was investigated by infecting wild type C57BL/6 mice
with F. tularensis LVS or the ΔaraC mutant intranasally after anesthetizing them through
intraperitoneal injection of ketamine and xylazine. Mice were inoculated with four different
doses (1x102, 1x103, 1x104, or 1x105 CFUs) in a volume of 20µl (10µl/nare) of F. tularensis
LVS or the ΔaraC mutant. Morbidity and mortality of the infected mice were observed for 15
days. Body weight and survival were recorded daily. Survival was expressed as the KaplanMeier survival curve, and the data were analyzed statistically by the Log-rank test (Figure 9).
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Figure 8. Design of macrophage cell culture assay.
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Figure 9. Mouse survival studies. C57BL/6 mice were infected with varying doses of F.
tularensis LVS and the ΔaraC mutant intranasally (n=5 mice/bacterial strain). Morbidity
and mortality of the infected mice were monitored and recorded daily for 15 days.
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3.7. RNA extraction
To determine the role of AraC as a global transcriptional regulator, we profiled whole
transcriptome of the ΔaraC mutant in response to oxidative stress. This technique provides an
quantitative measurement of RNA expression level [164] during oxidative stress. The
superoxide-generating compound, menadione, was used for treatment. Menadione (20 mg/ml)
was dissolved in 70% ethanol and filtered using 0.2m syringe filter (MILLEX-GP, Millipore
Express PES membranes, Millipore Ireland Ltd, Cork, IRL). F. tularensis LVS or the ΔaraC
mutant were suspended in MHB (0.2 OD600), and menadione was added for a final
concentration of 1.25mM. For untreated control, MHB was added alternatively, and bacterial
tubes were incubated for 1 hour at 37οC with 5% CO2. Bacteria were then centrifuged at 10000
rpm for 10 minutes at room temperature, and pellets were resuspended in 990 µl lysis buffer
(from Purelink RNA mini kit/Invitrogen) supplemented with 10µl 2-mercaptoethanol
following the manufacturer’s protocol. The bacteria were then lysed by vortexing, and 1 ml
TRIzol reagent (InvitrogenTM) was added to the lysate and mixed well. The lysate was
incubated at 25οC for 4 minutes. Cold chloroform was added to the lysate and mixed well. The
mixture was incubated for 2-3 minutes and centrifuged at 12000 rcf for 15 minutes at 4 οC until
an aqueous colorless solution containing the RNA is separated. After transferring the clear
solution into another tube, isopropanol was added, mixed, and incubated for 10 minutes at
room temperature. After that, the Spin cartridges with the collection tubes supplemented with
the kit were used to purify RNA. RNA samples were treated with DNase using Invitrogen TM
(TURBO DNA-free Kit). Pure RNA samples were stored at -80 οC.
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3.8. RNA sequencing
Purified RNA samples were sent to the Genomics Core Laboratory at the New York
Medical College for sequencing. Differentially expressed genes were evaluated based on
log2(fold change) value. The differential expression of F. tularensis LVS and ΔaraC mutant
genes was analyzed based on log2(fold change) of genes in the ΔaraC mutant as compared to
those in wild type F. tularensis LVS in the untreated, and the menadione treated samples. For
the downregulated genes, the expression of the araC gene which has been deleted in the
ΔaraC mutant was taken as 100%. Any gene that represented less than 50% of the log2(fold
change) of the araC gene was considered as downregulated. However, to further narrow the
number of genes identified as under the control of AraC, we considered the p-values and any
value less than 0.05 was considered significant. All the data analyzed were cumulative of two
independent experiments (Figure 10).

3.9. Quantitative real-time polymerase chain reaction (qRT-PCR)
qRT-PCR was used to confirm differentially expressed genes from the RNA
sequencing experiments. Gene-specific primers used for qRT-PCR are listed in Table 1. All
qRT-PCR experiments were performed using 96-well plates (MicroAmp Optical 96-Ell
Reaction Plate, Applied Biosystems, Inc., Foster City, CA, USA). Samples denaturation,
reverse transcription, and amplification were conducted using a 7500 Fast Real-Time PCR
System (Applied Biosystems, Inc., Foster City, CA, USA). The C T (cycle threshold) values of
both F. tularensis LVS and the ΔaraC mutant were provided by the qRT-PCR instrumentation.
These CT values are readily imported into Excel sheets to calculate ΔCT of each of the wild
type and ΔaraC mutant for every tested gene. For example, if we assumed that the wild type
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F. tularensis is A and the ΔaraC mutant is B, then the calculations are: ΔCTA= CT (target) A-CT
(control)

A and ΔCTB= CT (target) B- CT (control) B. Next, the ΔΔCT was calculated for every target

gene using the formula: ΔΔCT= ΔCTB- ΔCTA. After that, expression normalization was
calculated as 2-(ΔΔ CT). This indicated the fold change in gene expression of the ΔaraC mutant
as compared to the F. tularensis.

3.10. Statistical analysis
All results were analyzed using GraphPad Prism 6 software and were represented as
Mean ± Standard Deviation (SD). Comparisons among experimental groups were made using
one-way ANOVA. Survival data were plotted as the Kaplan-Meier survival curves, and
significance was statistically calculated by the Log-rank test. The statistically significant data
are considered as p-value < 0.05.

46

Figure 10. RNA sequencing protocol.
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4. RESULTS
The primary goal of this study was to investigate the role of AraC as a transcriptional
regulator of F. tularensis, and to understand its role in tularemia pathogenesis. In literature,
AraC has been reported to be a member of the AraC/Xyls transcriptional regulator family [139,
165-167]. AraC has been shown to regulate L-arabinose metabolism in E. coli and serves both
as an activator as well as a repressor [139, 168]. The role of AraC in F. tularensis LVS is not
characterized to date. In this study, we elucidated the role of AraC in gene regulation of F.
tularensis.
Our overall hypothesis was “AraC may have a unique role in transcriptional regulation of
multidrug efflux pump genes in addition to the genes involved in general metabolism as well
as the stress response.” We developed two specific aims to address our hypothesis.

Specific Aim 1: Phenotypic characterization of the araC gene deletion mutant (ΔaraC) of
F. tularensis LVS.
4.1. The genomic organization of the araC gene of F. tularensis LVS
The genomic organization of araC gene is shown in Figure 11A. The araC gene of F.
tularensis is transcribed divergently from the downstream operon encoding for components
EmrB, EmrA1, and SilC of MFS type MEP (Figure 11B). All the other Francisella strains
including the virulent F. tularensis Schu S4 and F. novicida exhibit an identical genomic
organization to that observed in F. tularensis LVS. A similar genomic organization is also
present in Burkholderia pseudomallei (B. pseudomallei). In E. coli, Yersinia pestis, and
Salmonella typhi, this gene is annotated as a transcriptional regulator rather than araC and is
transcribed in a similar direction as the upstream genes. Thus, the genomic organization of

48

araC gene in Francisella is unique. This also implies that AraC may have a unique role in
tularemia pathogenesis.
Sequence comparison of AraC transcriptional regulator within Francisella subspecies
revealed high similarity, ranging from 97% to 100%. However, AraC showed less homology
when aligned with the transcriptional regulator present in a similar genomic location in other
pathogenic bacterial species. Table 2 shows the identity percentage of some Gram-negative
pathogenic bacteria, including B. pseudomallei (51.35 %), S. typhi (47.62 %), Y. pestis (42.42
%), and E. coli (33.33 %), with the AraC amino acid sequence of F. tularensis LVS. We
determined that the AraC amino acid sequence of F. tularensis is highly conserved in almost
all Francisella subspecies. Multiple sequence alignment in Figure 12 using Clustal W
demonstrated that AraC protein sequences of all the pathogens used in this alignment exhibited
a

conserved

C-terminal

domain

(highlighted

grey),

with

a

consensus

motif

GxxxxxxFxxxxxxxxxxxP (G/F/P). This consensus sequence starts at amino acid 244 and ends
at amino acid 263 of AraC (FTL_0689).
Moreover, to demonstrate the protein binding motif logo sequence, we used one of the
most commonly utilized software, Meme (Multiple Em for Motif Elicitation), a visually rich
and informative logo representation of sequence alignment. The alignment identified the Cterminal and N-terminal conserved sequences of AraC protein of F. tularensis LVS compared
to E. coli AraC and Y. pestis VirF. Figure 13A demonstrates the conserved DNA binding
motif in the C-terminal domain, which is similar to the binding domain that we revealed using
Clustal W. In addition, we identified two protein binding motifs located in the N-terminal.
Figure 13B represents the signature motif of HPxM, and Figure 13C is the second binding
motif WxH. These N-terminal domains are unique, present in AraC of a few pathogens
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including all Francisella strains. Collectively, bioinformatic analysis of AraC suggests that
AraC transcriptional regulator of Francisella is unique and may be responsible for a
specialized role in the virulence of Francisella.
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Figure 11. Generation of the ΔaraC deletion mutant. (A) Genomic organization of the F.
tularensis LVS multidrug efflux pump (MEP) genes showing the presence of the araC
transcriptional regulator upstream of this set of genes and is annotated as FTL_0689. (B)
schematic diagram showing araC transcriptional regulator of F. tularensis (red box) is
transcribed divergently from the MEP components (blue dashed box), unlike other
organisms. (C) Deletion of araC and primer locations for the screening of araC mutant
indicated by grey arrows. (D) Confirmation of araC deletion by the PCR. The wild type F.
tularensis LVS and sodB gene primers were used as positive and internal controls,
respectively.
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Figure 12. Protein sequence alignment of the AraC of F. tularensis and XylS/AraC
family proteins from other pathogens. Multiple alignments were generated using Clustal
W software. The C-terminal region (highlighted in grey) shows a conserved DNA binding
motif GxxxxxxFxxxxxxxxxxxP (conserved residues are represented by red boxes and
arrows). The numbers in the right indicate amino acids location.
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Table 2: F. tularensis LVS AraC sequence alignment with other bacterial strains
Pathogen

Locus tag

Product

Identity

Accession

F. tularensis subsp.
tularensis Schu S4

FTT_1255c

AraC family transcriptional
regulator

99.65%

YP_170213

F. novicida U112

FTN_1274

98.91%

ABK90155

E. coli O25b:H4

WLH_02767

32.63%

ANK04028

E. coli K-12

U069_c0078

33.33%

AKK15826

E. coli

N/A

27.27%

AAA24640

S. enterica subsp.
enterica serovar Typhi

CJP42_0176

26%

AXR57446

Y. enterocolitica

RLY99535

28%

RLY99535

P. aeruginosa PAO1

PA1713

20.46%

AE004598_1

Transcriptional regulator,
AraC family
Transcriptional regulator
GadX
AraC family putative
transcriptional regulator
protein
DNA-binding transcriptional
regulator SoxS
HTH-type transcriptional
activator RhaS
Virulence regulon transcription
al activator VirF
transcriptional regulator ExsA
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Figure 13. AraC binding motifs are conserved. (A) AraC C-terminal region showing the
DNA binding domain (GxxxxxxFxxxxxxxxGxxP). (B and C) Protein binding motifs in the
N-terminal region of AraC.
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4.2. Generation of araC gene deletion mutant and the transcomplemented strain
The araC in-frame gene deletion mutant (ΔaraC) of F. tularensis LVS was generated
by an allelic replacement method and confirmed by PCR. Primers internal to the araC gene
amplified a fragment of 500 bp in the wild type F. tularensis LVS, while the absence of this
amplicon indicated deletion of araC gene (Figure 11C and 11D). The full-length araC gene
was amplified in the transcomplemented strain indicating the restoration of the araC gene in
the ∆araC mutant. Primers specific to the sodB gene were used as internal control and a PCR
fragment corresponding to the sodB gene was amplified in all the three strains tested, indicating
that the absence of araC gene-specific fragment in the araC mutant is not due to the lack of
input DNA. Furthermore, the in-frame gene deletion in the araC mutant was additionally
confirmed by DNA sequencing (data not shown).

4.3. Determining the involvement of AraC in L- arabinose utilization and metabolism
To determine if AraC transcriptional regulator is responsible for L-arabinose
metabolism, we tested the ability of the ΔaraC mutant to grow in the presence of L-arabinose
containing media. We prepared MH-chocolate agar plates containing 10g of either the Dglucose or L-arabinose. The plates were then streaked with F. tularensis LVS, the ΔaraC
mutant, or the transcomplemented strain. Two strains of E. coli, DH-5α and S17.1, were used
to serve as positive controls as both these strains can grow in the presence of arabinose. Our
results demonstrated that the ΔaraC mutant, the wild type F. tularensis LVS, and the
transcomplemented strain as well as E. coli DH-5α, and S17 strains were able to grow
sufficiently in the presence of D-glucose (Figure 14A). However, all three F. tularensis strains
showed traces of visible growth in the presence of L-arabinose, as compared to the E. coli
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strains (Figure 14B). These results demonstrate that all F. tularensis LVS strains fail to grow
in the presence of L-arabinose indicating that Francisella cannot utilize L-arabinose as a
carbohydrate source and that D-glucose is the preferred sugar source for F. tularensis LVS. A
trace amount of growth for the wild type F. tularensis, the araC mutant and the
transcomplemented strains were observed when grown on MH-chocolate agar plates
containing L-arabinose as the sole sugar source. This indicated that either the Francisella
strains poorly utilize L-arabinose or that components of the MH-agar media were supporting
this scant growth. To address this notion, we generated bacterial growth curves using CDM
with three different sugar compositions: one with neither glucose nor arabinose, one with Dglucose only, and the other with arabinose as the sole carbohydrate source. Both the ΔaraC
mutant and the wild type F. tularensis LVS grew very well in glucose-containing CDM
(Figure 14C). Both strains grew at a similar rate and reached an approximate OD600 of 2.4
after 40 hours of incubation. However, when the CDM was supplemented with L-arabinose
only (Figure 14D) or with no sugar (Figure 14E), both the wild type and the mutant strains
reached an OD600 of 0.5 after a short period of growth and then entered into a stationary phase,
indicating their growth was largely affected by the lack of appropriate sugars in the medium.
Collectively, these results demonstrate that D-glucose is essential for the growth of F.
tularensis and it cannot utilize L-arabinose. Furthermore, these results also demonstrate that
AraC of F. tularensis LVS is likely not involved in the regulation of L-arabinose metabolism.
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Figure 14. Growth of F. tularensis LVS strains in the presence of different
carbohydrate substrates. The wild type F. tularensis LVS, the ΔaraC mutant, or the
transcomplemented strains were grown in MH-chocolate agar containing glucose (A), or
arabinose (B). E. coli DH-5α and E. coli S17.1 were used as positive controls. Growth curves
of the wild type F. tularensis LVS and ΔaraC mutant in CDM supplemented with glucose
(C), arabinose (D), or in the absence of sugar (E). (n = 3)
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4.4. Investigating the role of AraC in the regulation of EmrA1 MEP components
In the genomic organization (Figure 11A), araC of F. tularensis is divergently
transcribed from the genes encoding major facilitator superfamily type multidrug efflux pump
genes: emrB, emrA1, and silC. Such a unique organization indicated that AraC might be
involved in the regulation of these downstream genes. Thus, we first tested the expression
levels of emrB, emrA1, and silC genes in the ΔaraC mutant and compared them with those in
the wild type F. tularensis LVS by qRT-PCR. The results shown in Figure 15 indicated that
expression of all these three genes was significantly downregulated in the ΔaraC mutant in
stark contrast to the wild type F. tularensis LVS, suggesting that AraC may have a role in the
regulation of the components of the Emr multidrug efflux pump.

4.4.1. The sensitivity of ΔaraC mutant to oxidants
We next investigated to confirm if the phenotype of the ΔaraC mutant is similar to those
described for the emrA1 and ΔsilC mutants. EmrA1 is a membrane fusion protein and SilC is
an outer membrane protein of major facilitator superfamily type MEP in F. tularensis LVS
[87, 112]. Loss of both emrA1 and silC results enhanced sensitivity of these mutants towards
oxidative stress. Therefore, we investigated if AraC contributes to the resistance of F.
tularensis LVS towards oxidants via regulating MEP components emrA1 and silC. We
investigated the sensitivity of ΔaraC mutant to peroxides and superoxide (O2− ) generating
compounds.
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4.4.1.1. The araC mutant of F. tularensis LVS is sensitive to hydrogen peroxide
To determine the sensitivity of ΔaraC mutant to peroxides, we used organic peroxides
and H2O2 in a spot assay. The emrA1 mutant was used for a comparison. We performed
bacterial killing assay by exposing wild type F. tularensis LVS, the ΔaraC mutant, the
transcomplemented strain ΔaraC+paraC, and the emrA1 mutant to varying concentrations of
H2O2, incubated for one and three hours, and plated on MH-chocolate agar to determine the
bacterial viability. The results showed an enhanced killing of the ΔaraC mutant when exposed
to increasing concentrations of H2O2 for one and three hours as compared to the wild type F.
tularensis LVS. The transcomplementation restored the wild type phenotype and showed
similar sensitivity after one and three hours of incubation. The emrA1 mutant showed an
enhanced killing as compared to the wild type F. tularensis LVS after one hour of exposure to
H2O2 (Figure 16A). These results indicate that ΔaraC mutant, similar to the emrA1 mutant, is
sensitive to the increasing concentration of H2O2.
We next performed the bacterial killing assay to quantitate the bacterial numbers after
exposure to H2O2. We exposed wild type F. tularensis LVS, the ΔaraC mutant, the
transcomplemented strain, and the emrA1 mutant (adjusted to an OD600 of 0.2) to 8 mM of
H2O2, a concentration that had been demonstrated bacterial killing in spot assays. Ten-fold
dilutions of the bacterial strains after one hour of exposure to H 2O2 were then plated on MHchocolate agar plates. The results showed that about 40% of the ΔaraC and the emrA1 mutants
were killed, which was significantly higher than the percentage of bacterial killing (28%)
observed for the wild type F. tularensis LVS after one hour of exposure. The
transcomplemented strain showed a significant increase in killing as compared to the wild type
F. tularensis LVS and failed to restore the wild type phenotype possibly due to the loss of the
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transcomplementation plasmid in the absence of antibiotic selection pressure (Figure 16B).
Furthermore, the bacterial counts revealed an approximately 12-fold decrease in the viability
of ΔaraC and the emrA1 mutants as compared to the wild type F. tularensis LVS (Figure
16C). Collectively, these results demonstrate that loss of araC, similar to the emrA1 mutant,
is associated with enhanced sensitivity of the ΔaraC mutant to H2O2.
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Figure 15. qRT-PCR analysis of silC, emrA1, and emrB genes. The data shown are
representative of three independent experiments. Data are analyzed using Two-tailed student
T-test. *p<0.05.
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Figure 16. The sensitivity of the araC mutant to H2O2. (A) Wild type F. tularensis LVS,
the ΔaraC mutant, ΔaraC+paraC, or the emrA1 mutant were exposed to the indicated
concentration of H2O2 for one hour and three hours in a spot assay. Experiments are
representative of two independent experiments. (B and C) Bacterial killing assay using 8
mM H2O2. The data were analyzed using one-way ANOVA. The data from the bacterial
killing assay experiments are cumulative of three independent experiments. ***p<0.001.
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4.4.1.2. The ΔaraC mutant is sensitive to organic peroxides
The sensitivity of the ΔaraC mutant was also determined against organic peroxide,
TBH. Bacteria were exposed to varying concentrations of TBH, and the bacterial viability was
determined by spot assay. Bacterial viability was similarly reduced in both the wild type F.
tularensis LVS and the ΔaraC mutant after 1 hour of exposure to TBH. However, after three
hours of incubation, there was an enhanced killing of the ΔaraC mutant as compared to the
wild type F. tularensis LVS, indicating that prolonged exposure of the ΔaraC mutant to TBH
results enhanced sensitivity to TBH (Figure 17A).
Next, we investigated sensitivity of the ΔaraC mutant to CHP. The ΔaraC mutant
exhibited enhanced sensitivity to CHP after one hour and three hours of exposure to CHP as
compared to the wild type F. tularensis LVS (Figure 17B). We further confirmed these results
by performing disc diffusion assay. Significantly larger zones of inhibition (11.25±0.25 mm)
were observed for the ΔaraC mutant as compared to those observed for the wild type F.
tularensis LVS (9.25±0.25 mm) and the transcomplemented strain (10.25±0.25 mm) when
exposed to a 0.1M concentration of CHP. The difference was lost when a higher concentration
of 0.5M of CHP was used (Figure 17C). Taken together, these results demonstrate that the
ΔaraC mutant is highly sensitive to organic peroxides TBH and CHP. This phenotype has also
been demonstrated for both the emrA1 and silC mutants of F. tularensis LVS as well as Schu
S4 [87, 112].
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Figure 17. Sensitivity of ΔaraC mutant to organic peroxides. Spot assay of F. tularensis
LVS and the ΔaraC mutant at varying concentrations of TBH starting from 6.3 mM (A) and
CHP starting from 0.7 mM CHP (B). Disc diffusion assay of the wild type F. tularensis
LVS, the ΔaraC mutant, and the transcomplemented strain using the indicated
concentrations of CHP (C). Zones of inhibition from bacteria treated with 0.25 M, 0.1 M, or
0.5 M CHP are shown. The data shown in C are cumulative of two independent experiments
and are analyzed using one-way ANOVA. *** p<0.001.
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4.4.1.3. The ΔaraC mutant of F. tularensis LVS is sensitive to superoxidegenerating compounds
Both the emrA1 and silC mutants are also sensitive to superoxide-generating
compounds. Since we observed that the ΔaraC mutant had higher sensitivity towards
peroxides, similar to the emrA1 and silC mutants, we also tested sensitivity of the ΔaraC
mutant to superoxide-generating compounds pyrogallol, paraquat, and menadione.
Enhanced killing of the ΔaraC mutant was observed when exposed to increasing
concentrations of pyrogallol, at one and three hours post-exposure, as compared to the wild
type F. tularensis LVS. The trans-complementation did not restore the wild type phenotype.
The emrA1 mutant as reported earlier showed enhanced killing similar to the ΔaraC mutant
after one and three hours of exposure to pyrogallol (Figure 18A).
Next, we confirmed our observations by performing disc diffusion assay by exposing
the wild type F. tularensis LVS, ΔaraC mutant, and the transcomplemented strain to sterile
discs impregnated with 50mg, 25mg, or 12.5mg of pyrogallol. The plates were incubated, and
zones of inhibition were measured in mm (Figure 18B). The ΔaraC mutant exhibited
significantly larger zone of inhibition (19.00±0.41) as compared to that of the wild type F.
tularensis LVS (17.25±0.48).
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Figure 18. Sensitivity of ΔaraC mutant to pyrogallol. (A) Spot assay of F. tularensis LVS,
the ΔaraC mutant, ΔaraC+paraC, and the emrA1 mutant. Bacteria were exposed to a
concentration gradient of pyrogallol for one and three hours and plated on MH-chocolate
agar plates. (B) Disc diffusion assay using indicated concentrations of pyrogallol and zones
of inhibition for 50 mg/mL concentration are shown. The data shown are cumulative of two
independent experiments and are analyzed using one-way ANOVA. *p<0.05.
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We also tested sensitivity of the ΔaraC mutant to superoxide-generating compound
paraquat which generates superoxide radicals intracellularly. However, we did not observe any
enhanced susceptibility of the ΔaraC mutant to paraquat when tested by spot assay, bacterial
killing assay or the disc diffusion assay. Similar results were also observed for the emrA1
mutant (Figure 19). Results similar to those observed for paraquat were obtained when the
sensitivity of the ΔaraC mutant was tested against another superoxide-generating compound
menadione (Figure 20). These results demonstrate that the ΔaraC mutant exhibits enhanced
sensitivity only towards pyrogallol as compared to the wild type F. tularensis LVS but not
towards paraquat or menadione. Moreover, the patterns of the sensitivity of the ΔaraC and the
emrA1 mutant to pyrogallol and paraquat are identical. These results indicate that the
sensitivity of the ΔaraC mutant to superoxide-generating compounds varies depending on the
location and mechanism of generation of superoxide radicals. Taken together, these results
demonstrate that the ΔaraC mutant exhibits an identical oxidant sensitive phenotype similar to
that observed for the emrA1 mutant.
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Figure 19. Sensitivity of ΔaraC mutant to paraquat. (A) Spot assay of F. tularensis LVS,
ΔaraC mutant, trans-complement, and emrA1 mutant. (B) percentage of bacterial killing and
(C) CFUs after exposing to 0.5 mM paraquat, expressed as Log10 CFU/mL. (D) Disc
diffusion assay using the indicated concentrations of paraquat. (E) Zones of inhibition
measurement when bacteria were treated with 0.9 mg of paraquat, expressed in mm. The
data shown are cumulative of three independent experiments. The data are analyzed using
one-way ANOVA. *p<0.05.
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Figure 20. Sensitivity of ΔaraC mutant to menadione. (A) spot assay of ΔaraC mutant as
compared to F. tularensis LVS. (B) Disc diffusion assay using the indicated concentrations
of menadione. (C) Measurement of the zones of inhibition for bacteria treated with 1 μg
menadione, expressed in mm. The data shown are cumulative of three independent
experiments. The data are analyzed using one-way ANOVA.
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4.4.2. AraC is not involved in resistance to silver compounds
In addition to providing resistance to oxidants, EmrA1 and SilC also contribute towards
resistance to silver compounds [87]. We tested sensitivity of the ΔaraC mutant to varying
concentrations of silver nitrate in a spot assay to determine its contribution to resisting silver
compounds. The results indicated no enhanced sensitivity of the ΔaraC mutant to increasing
concentrations of silver nitrate as compared to the wild type F. tularensis LVS. However, the
emrA1 mutant was found to be highly sensitive to silver nitrate following one and three hours
of exposure (Figure 21). These results suggest that AraC is not involved in resistance to silver
compounds.
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Figure 21. Sensitivity of ΔaraC mutant to Silver nitrate (AgNO3). Spot assay of F.
tularensis LVS, ΔaraC mutant, and emrA1 mutant. 25 mM of silver serially diluted in a 96well plate and incubated for one and three hours and plated using a replica plating method.
The results are representative of three independent experiments conducted.
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4.4.3. AraC is not involved in rendering resistance towards antibiotics
The MEP components EmrA1 and SilC of the Emr multidrug efflux pump are required
for efflux of antibiotics and antibiotic resistance [87, 112]. We further investigate if AraC,
similar to EmrA1 and SilC, is involved in antibiotic resistance. We tested sensitivity of the
ΔaraC mutant to Streptomycin (10 μg), Gentamicin (10 μg), Novobiocin (30 μg),
Erythromycin (15 μg), Tetracyclin (30 μg), Nalidixic acid (30 μg), Polymyxin B (300 units),
and Chloramphenicol (30 μg). As shown in Figure 22, the ΔaraC mutant was found to be
equally sensitive to all the antibiotics tested as the wild type F. tularensis LVS. This result
suggests that AraC does not contribute to antibiotic resistance.
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Figure 22. The ΔaraC mutant does not exhibit enhanced sensitivity towards antibiotics.
Disc diffusion assay of the ΔaraC mutant and F. tularensis LVS using Streptomycin,
Gentamicin, Novobiocin, and Erythromycin in (A), Tetracyclin, Nalidixic acid, Polymyxin
B, and Chloramphenicol in (B). Measurement of zones of inhibition of the indicated
antibiotics and their concentrations (C). The results are cumulative of three independent
experiments. The data are represented as Mean±SEM.
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Specific Aim 2: Investigation of the role of AraC as a global transcriptional regulator in
F. tularensis LVS
Our preceding results demonstrated the involvement of AraC in oxidative stress
resistance. In Specific Aim 2, we investigated the genes that are being controlled by AraC
transcriptional regulator. Activation of AraC/XlyS transcriptional regulators requires the
presence of a substrate such as arabinose that activates them. Studies conducted in Specific
Aim 1 failed to identify the specific substrate of AraC of F. tularensis. However, the ΔaraC
mutant did demonstrate sensitivity towards oxidative stress. We hypothesized that “AraC of
Francisella gets activated in the presence of oxidative stress and regulates the expression of
genes required for survival under the oxidative stress conditions.” To address this hypothesis,
we investigated the transcriptome of the ΔaraC mutant when exposed to oxidative stress and
compared to that of F. tularensis LVS.
We observed that the ΔaraC mutant was sensitive to several superoxide-generating
compounds and peroxides. However, ΔaraC mutant did not exhibit any enhanced sensitivity
towards superoxide-generating compound menadione (Figure 20). We chose menadione to
induce the oxidative stress as this oxidant would not kill either the wild type or the mutant
bacteria but would induce an oxidative stress response. Wild type F. tularensis LVS and the
ΔaraC mutant bacteria were either left untreated or treated with menadione (1.25 mM
menadione) and incubated for 1 hour at 37οC. RNA was isolated and RNA sequencing was
performed.
Differential gene expression of F. tularensis LVS and the ΔaraC mutant was analyzed
based on Log2(fold change) of the gene expression levels comparing the ΔaraC mutant to the
wild type F. tularensis LVS and comparing menadione treated samples to the untreated. For
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the downregulated genes, the expression of the araC gene which has been deleted in the ΔaraC
mutant was taken as 100%. Any genes that represented less than 50% of the Log2(fold change)
of the araC gene was considered as downregulated. However, to further narrow the number of
genes identified as under the control of AraC, we considered the p-values and any value less
than 0.05 was considered significant. All the data analyzed were cumulative of two
independent experiments.

4.5. Determination of differentially expressed genes in the ΔaraC mutant not exposed to
oxidative stress
At first, we identified differentially expressed genes in the ΔaraC mutant in comparison
to the wild type F. tularensis LVS when bacteria were not exposed to oxidative stress. The
Log2(fold change) of the araC gene in the ΔaraC mutant as compared to the wild type F.
tularensis LVS was observed to be -0.67. Thus, 50% of this value (=-0.3) was used as a cutoff to determine the downregulated genes in the ΔaraC mutant. The analysis showed that only
the araC gene (FTL_0689) was significantly downregulated in the ΔaraC mutant not exposed
to menadione. These results demonstrate that AraC is not required for gene regulation of F.
tularensis under normal growth conditions.

4.6. Determination of differentially expressed genes in the ΔaraC mutant exposed to
oxidative stress
Next, we identified the differentially expressed genes in the ΔaraC mutant as compared
to the wild type LVS when the bacteria were exposed to oxidative stress. The lowest expression
with a log2(fold change) of -1.08 was observed for the ΔaraC mutant. Based on this, we
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selected a value of -0.5 or +0.5 Log2(fold change) as a cut-off to determine the differentially
expressed genes in the ΔaraC mutant.

4.6.1. Exposure of ΔaraC mutant to oxidative stress results in downregulation
of genes encoded on Francisella Pathogenicity Island (FPI)
The RNA Sequencing results identified five downregulated genes encoded as an
operon within the FPI. The expression of these genes remained unaltered when the ΔaraC
mutant was not exposed to oxidative stress (Figure 23). These genes encode factors of F.
tularensis essential for intracellular survival and virulence [169]. The pdpC gene encodes a
pathogenicity determinant protein that does not contribute to intracellular survival but is
required for virulence in mice. On the other hand, pdpE is neither required for virulence nor
intracellular survival. The iglJ gene product is required for intracellular growth,
cytopathogenicity and virulence in mice, whereas iglI plays an important role in the
phagosomal escape, cytopathogenicity, and virulence in mice [170]. The dotU gene product is
an essential structural component of the Type VI secretion system (T6SS) of F. tularensis and
is absolutely required for the functioning of T6S. Overall, these results indicate that AraC
regulates expression of virulence-associated genes under oxidative stress conditions.
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Figure 23. AraC regulates the expression of FPI genes when exposed to oxidative stress.
A. Expression profile of FPI genes in the ΔaraC mutant upon exposure to menadione. The
operon is indicated by the box. Data shown are from two independent experiments and
expressed as Log2(fold change). B. The structure of T6SS. Modified from Clemens. D. L.,
Lee. B., Horwitz. M. A., 2018 [171] C. T6SS is required for the intracellular replication
phase of F. tularensis indicated by red circle. Modified from Jones et al., 2012 [23].
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4.6.2. The

ΔaraC

mutant

exhibits

a

dose-dependent

attenuation

of

intramacrophage growth
During its intracellular residence, F. tularensis is exposed to oxidative stress. We next
verified if the downregulated FPI genes in the ΔaraC mutant when exposed to oxidative stress
is associated with its impaired survival in macrophages. We used Raw macrophage cell line as
host. We infected murine raw macrophages with the wild type F. tularensis LVS, the ΔaraC
mutant, and the transcomplemented strain at 1, 10, 100, and 500 MOIs. The cells were lysed
at 4 and 24 hours post-infection to determine the numbers of bacteria that invaded cells and
replicated intracellularly. The results revealed that all the three Francisella strains invaded the
macrophages with equal efficacy irrespective of the MOI used and identical bacterial numbers
were recovered from all the three strains tested at 4 hours post-infection. At 24 hours, the
differences were more prominent. At an MOI of 1, significantly less ΔaraC mutant bacteria
(4.1±0.0 Log10 CFU/ml) were recovered from the infected macrophages as compared to the
wild type strain (6.3±0.0 Log10 CFU/ml). Transcomplementation of the ΔaraC mutant partially
restored the wild type phenotype (Figure 24A). At an MOI of 10 infection dose, there were
fewer bacteria recovered from the macrophages infected with the ΔaraC mutant (6.8±0.0
Log10 CFU/ml) as compared to the wild type F. tularensis LVS (7.1±0.0 Log10 CFU/ml)
(Figure 24B). Similar results were observed when the infection dose was increased to 100
MOI with macrophages infected with the ΔaraC mutant harbored significantly fewer bacteria
(8.3±0.0 Log10 CFU/ml) than the wild type (8.5±0.0 Log10 CFU/ml) at 24 hours post-infection
(Figure 24C). At a saturating infection dose of 500 MOI, the difference in numbers of bacteria
recovered from the ΔaraC mutant infected cells and the wild type F. tularensis infected
macrophages was lost and equal numbers of bacteria were recovered from both groups of
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infected macrophages (Figure 24D). Altogether, results from the macrophage assays
demonstrate that ΔaraC mutant is attenuated for intramacrophage survival. The attenuation of
intramacrophage growth of ΔaraC mutant is dose-dependent. These results also corroborate
findings of the gene expression studies that AraC-dependent gene expression of the FPI genes
is required for intramacrophage survival of F. tularensis.
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Figure 24. The ΔaraC mutant is attenuated for intramacrophage survival. Dose
dependent attenuation of intramcarophage growth of ΔaraC mutant at an MOI: 1 (A), 10
(B), 100 (C), and 500 (D). The data shown are cumulative of three independent experiments
and are analysed using one way ANOVA. *** p<0.001; ** P<0.01.
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4.6.3. The ΔaraC mutant exhibits attenuation of virulence in mice in a dosedependent manner
To further establish that AraC-dependent regulation of FPI genes observed under
oxidative stress is not only required for intramacrophage growth and survival, but also for
virulence in mice, we performed in vivo experiments in a mouse model of tularemia. We
infected C57BL/6 mice intranasally with incremental doses (1x10 2, 1x103, 1x104, or 1x105
CFUs) of F. tularensis LVS or the ΔaraC mutant and monitored their survival and body
weights daily for 15 days (Figure 25). It was observed that the ΔaraC mutant was attenuated
for virulence as compared to the wild type F. tularensis LVS. However, a dose-dependent
increase in virulence of the ΔaraC mutant was observed. All of the mice infected with 1x102
and 1x103 CFUs of the ΔaraC mutant survived the infection whereas 20% mice infected with
1x102 CFUs and 40% of those infected with 1x103 of the wild type F. tularensis LVS
succumbed to infection (Figures 25A and 25B, left panels). All mice infected with 1x104 and
1x105 of F. tularensis LVS also succumbed to the infection by day 10. However, 20% of mice
infected with similar doses of the ΔaraC mutant survived the infection. All infected mice lost
body weight during the first 3-6 days and then gradually regained their original body weight
indicating that all mice received the infection. Collectively, these results demonstrate that AraC
by regulating the FPI genes contributes to intramacrophage growth and virulence in mice in a
dose-dependent manner.
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Figure 25. The ΔaraC mutant exhibits a dose-dependent attenuation of virulence in
mice: C57BL/6 mice inoculated with 1x102 (A), 1x103 (B), 1x104 (C), or 1x105 (D) CFU of
F. tularensis LVS or the ΔaraC mutant intranasally. Survival and body weights of infected
mice (n=5/group) were recorded for 15 days. The survival curves are plotted as KaplanMeier survival curve (left panels). Body weights represented as Mean ±S.D. are shown in
the right panels.
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4.6.4. Exposure of ΔaraC mutant to oxidative stress results in differential
expression of stress response genes
RNA Sequencing analysis also unveiled differential expression of another three genes,
part of a stress response operon, in the ΔaraC mutant. Expression of these genes was
significantly affected upon treatment with menadione. These three downregulated genes
encode AroA, RnhA, and a hypothetical protein. rnhA gene (-0.48 Log2-fold change) encodes
Ribonuclease H, which protects bacteria from killing by oxidative stress [172]. rnhA is a multifunctional protein which is also actively involved in bacterial growth as simultaneous deletion
of rnhA, rnhB, and rnhC leads to lethality in Bacillus subtilis [173]. The findings indicate that
AraC could be involved in regulation of F. tularensis ribonuclease H abundance under
oxidative stress (Figure 26A).
Interestingly, another gene, rpoH, which encodes a sigma factor that shares homology
with the σ32 heat-shock family, was also downregulated in the ΔaraC mutant irrespective of
its exposure to oxidative stress [149]. RpoH modulates expression of several genes including
stress response genes groEL/S, clpB, FTL_1957, dnaK, dnaJ, and hsp40 [174]. To investigate
whether the absence of ΔaraC could change the expression profile of these heat shock proteins
while exposed to oxidative stress, expression of groES, clpB, FTL_1957 dnaK, dnaJ, and
hsp40 was determined by qRT-PCR. It was observed that expression of gorEL, dnaK, dnaJ
and hsp40 genes that are primarily involved in heat-shock response was significantly
upregulated in the ΔaraC mutant. Collectively, these results indicate that AraC serves to
positively regulate the expression of rpoH which in-turn negatively regulates the expression of
heat-shock proteins (Figure 26B).
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Further, to verify the participation of AraC in regulating heat-shock response, we
conducted thermal resistance experiment in which bacteria were exposed to a high temperature
(48οC), higher than the homeostatic temperature (37οC). The transcomplemented strain was
utilized as a positive control because araC in the transcomplemented vector is under the control
of GroEL promotor, activated at high temperature. Figure 26C shows that the viabilities of all
these three Francisella strains were not affected when exposed to a temperature of 37 οC for 1
hour. The findings indicate that at the physiological temperature, AraC exerts no benefit or
hindrance to F. tularensis growth.
Next, we induced high-temperature stress by growing the bacteria at 48 οC (Figure
26D). At the start point, the CFU/ml for these three Francisella strains were set approximately
equal. After 1 hour of incubation, these three strains exhibited a significant decrease in the
viable bacterial count. The numbers of the ΔaraC mutant bacteria (7.8±0.0 Log10CFU/ml)
were significantly higher than the wild type F. tularensis LVS (7.5±0.0 Log10CFU/mL). The
transcomplemented strain survived better than the former two Francisella strains tested, with
significantly higher numbers of bacteria (8.3±0.0 Log10CFU/mL) survived at the higher
temperature. Overall, the results indicate that AraC of F. tularensis LVS regulates the
expression of heat-shock proteins negatively and facilitates its survival under extreme stress
conditions.
In addition to the aforementioned, aroA gene (-0.55 Log2-fold change) was also
downregulated in ΔaraC mutant in response to oxidative stress. aroA encodes 3phosphoshikimate 1-carboxy-acyltransferase, which is an enzyme required in the shikimate
pathway responsible for the bio-synthesis of enolpyruvyl shikimate-3-phosphate, inorganic
phosphate, folate, and aromatic amino acids [175] (Figure 26E). This pathway is important

84

for bacterial metabolism and homeostasis [175]. The finding that downregulation of the aroA
RNA abundance in ΔaraC mutant after treatment with menadione implied that AraC is
involved in modulation of F. tularensis metabolism.
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Figure 26. AraC regulates stress response genes of F. tularensis LVS. (A) Expression
profile of genes involved in heat and stress response in the ΔaraC mutant as compared to
the wild type F. tularensis LVS untreated or treated with menadione. Data are cumulative
of 2 independent experiments (B) qRT-PCR analysis of indicated heat-shock proteins in the
ΔaraC mutant and the wild type F. tularensis LVS treated with menadione. The data shown
are cumulative of three independent experiments. Data were analyzed using Two-tailed
student T-test. (C) CFU of the ΔaraC mutant, the wild type F. tularensis LVS, and the
transcomplemented strain on exposure to 37οC versus 48οC for I hour (D). (E) The shikimate
pathway required for aromatic amino acid synthesis showing the involvement of aroA gene
in the sixth step. Modified from Lutke-Eversloh, T. & Stephanopoulos. G., 2005 [176]. The
results are cumulative of three independent experiments. The data were analyzed using one
way ANOVA. *** p<0.001, ** p<0.01, * p<0.05, ns= non-significant.
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4.6.5. Genes responsible for energy production during oxidative stress

are

differentially regulated in the araC mutant
In addition to FPI and heat-shock proteins, RNA sequencing identified a set of genes
responsible for the production of ATPases that were downregulated in the ΔaraC mutant in
the presence of oxidative stress (Figure 27A). These genes transcribed on a single operon are
required for catalysis, synthesis, and hydrolysis of ATP [177]. They are also part of transmembrane proton (H+) translocator in prokaryotes [178]. ATP synthases are composed of two
molecules: F0 is attached to the periplasmic membrane and F1 extends to the cytoplasmic space
and forms the catalytic region of the enzyme [177] (Figure 27B). RNA Sequencing analysis
revealed downregulation of ATP synthase subunits, except A subunit of F 0 was upregulated in
the ΔaraC mutant post-exposure to menadione. Three of the genes affected to the greatest
extent were those encoding ATP synthase subunits of F1 molecule: γ, β, and AtpC (ε).
Altogether, these results demonstrate that AraC of F. tularensis differentially regulate the
expression of genes involved in energy production under oxidative stress.
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Figure 27. AraC differentially regulates the expression of genes involved in energy
production during oxidative stress. (A) Gene expression profile shows differentially
expressed ATP synthase genes in the ΔaraC mutant in the normal versus oxidative stress
conditions. The data are derived from two independent experiments. (B) Illustration of the
ATPase structure showing the main two molecules F0 and F1 and their subunits. Modified
from Sobti, M., et al., 2016 [179].
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4.6.6. AraC of F. tularensis positively regulates key components of TCA cycle
during oxidative stress
Exposure of the ΔaraC mutant to menadione downregulated expression of genes
involved in metabolism encoded on four different operons. One of these genes encodes the
enzyme pyruvate dehydrogenase subunits: E1, E2, and E3, required for the biosynthesis of
Acetyl-CoA, an enzyme that initiates the TCA cycle [180]. Among the three subunits, E3 or
dihydrolipoyl dehydrogenase encoded by lpd was downregulated in the ΔaraC mutant exposed
to oxidative stress as compared to the wild type F. tularensis LVS. The other two subunits, E1
pyruvate dehydrogenase (AceE) and E2 digydrolipoyl transacetylase (AceF), were also
downregulated in the ΔaraC mutant. The results demonstrate that AraC activates the TCA
cycle in F. tularensis under oxidative stress (Figure 28).
The expression of genes encoded on another operon was downregulated in the ΔaraC
mutant. This operon comprised of the genes required for the biosynthesis of pantothenate
(vitamin B5), which is the central component of coenzyme-A [181]. The RNA Sequencing data
analysis revealed that coaX gene encoding type III pantothenate kinase was downregulated in
the ΔaraC mutant as compared to the wild type when subjected to oxidative stress. The analysis
also exhibited downregulation of aspartate-1-decarboxylase panD gene, required for the
formation of β-alanine from L-aspartate [182], the panC gene encoding the pantothenate
synthase that employs β-alanine and L-pantoate for the production of pantothenate [183]. The
expression levels of panB (ketopantoate hydroxymethyltransferase) and panG (ketopantoate
reductase) were also downregulated in menadione treated ΔaraC mutant as compared to the
wild type F. tularensis LVS. Enzymes, PanB and PanG, catalyze the conversion of 2oxoisovalerate to 2-dehydropantoate and pantoate, respectively [182]. Altogether, these results
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indicate that, under oxidative stress, AraC of F. tularensis positively activates the pantothenate
biosynthesis pathway that is required for coenzyme-A formation to initiate the TCA cycle [181,
184].
Furthermore, exposing ΔaraC mutant to oxidative stress altered the expression of genes
encoded on an additional metabolic operon. This operon harbors three genes; pgk, pyk, and
fba. The pgk gene encodes phosphoglycerate kinase, an enzyme that catalyzes the formation
of ATP from ADP [185]. The pyk gene, encoding for pyruvate kinase [186], which is involved
in the production of ATP and pyruvate, crucial for several metabolic pathways including the
TCA cycle [186]. Moreover, the fba gene was downregulated to a greater extent in the ΔaraC
mutant post-exposure to menadione. This gene encodes fructose-bisphosphate aldolase class
II (FBA), which is required for the formation of fructose 1,6-bisphosphate (FBP) through the
gluconeogenesis and glycolysis pathways in Francisella. [187]. FBA is required for bacterial
virulence and is essential for intracellular survival, indicating the significance of these
metabolic pathways in bacterial pathogenesis [187]. Thus, downregulation of this operon
suggests that AraC of F. tularensis positively regulates glucose metabolic pathways in addition
to the TCA cycle during oxidative stress to sustain intracellular survival of F. tularensis.
In addition to the genes above, RNA expression levels of a set of metabolic genes were
changed in the ΔaraC mutant when treated with menadione. This operon encodes key enzymes
that are implicated in the TCA cycle. The two most downregulated genes were sucA and sucB
encoding oxoglutarate dehydrogenase subunits E1 and E2, respectively. This enzyme catalyzes
the transformation of 2-oxoglutarate into succinyl-CoA in the TCA cycle [188] and reduction
in the RNA expression level of these genes indicate that oxoglutarate dehydrogenase activity
of F. tularensis is deactivated in the ΔaraC mutant during oxidative stress. Furthermore, the
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genes, tpiA, glmM, and apt, encoding triosephosphate isomerase, phosphoglucosamine mutase
and adenine phosphoribosyltransferase required for gluconeogenesis pathway, were all
downregulated in the ΔaraC mutant during oxidative stress. The remaining genes within the
operon were impacted to a lower extent in the ΔaraC mutant, upon treatment with menadione,
including secG that codes for the preprotein translocase subunit SecG and genes that code for
the succinate dehydrogenase enzyme contributing to the TCA cycle and oxidative
phosphorylation pathway [189, 190]. Succinate dehydrogenase is composed of 4 subunits:
SdhA, SdhB, SdhC, and SdhD, and their expression remained unaltered in the ΔaraC mutant
as compared to the wild type (Figure 28).
Collectively, the RNA sequencing data analysis indicate that inducing oxidative stress
in the ΔaraC mutant diminishes the expression of various genes encoding key elements of the
metabolic pathways; TCA, and electron transport channels. Thus, AraC as a transcriptional
regulator plays a significant regulatory role in the metabolism of F. tularensis required for
survival and pathogenesis during oxidative stress.
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Figure 28. AraC is involved in the regulation of genes encoding key metabolic enzymes.
(A) Gene expression profile of the ΔaraC mutant as compared to the wild type F. tularensis
LVS of genes encoded on four operons (operons labeled by blue boxes). Genes prodcut
composing TCA cycle key enzymes are labled by blue parenthesis to the right. The Log2(fold
change) values are indicated. The data represent the average of gene expression from two
independent experiments. (B) Pathway of glucose metabloism ending in TCA cycle.
Enzymes downregulated by ΔaraC mutant during oxidative stress are highlited in red.
Modified from Seidl, K., et al., 2009 [191].
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4.6.7. AraC-dependent transcription of regulatory proteins
We identified an additional set of genes encoded on operons that were differentially
expressed in the ΔaraC mutant as compared to the wild type F. tularensis LVS after
induction of oxidative stress (Figure 29A). One of the operons is composed of genes
encoding: trkA, amino acid antiporter, and a hypothetical protein that was downregulated to
a great extent when the ΔaraC mutant was exposed to the oxidative stress. The trkA gene
encodes a potassium uptake protein. Moreover, the expression level of two genes: rpoB and
rpoC, on another operon was significantly downregulated in the menadione treated ΔaraC
mutant. These genes encode two of the RNA polymerase core proteins: the β (RpoB) and β’
(RpoC) subunits [149] (Figure 29B), indicating that AraC is also involved in regulating F.
tularensis transcriptional process during oxidative stress. Another gene (FTL_1051) that
encodes NAD(P)/FAD-dependent oxidoreductase was upregulated in the ΔaraC mutant as
compared to the wild type F. tularensis LVS. This enzyme is known to catalyze the redox
reactions of nicotinamide adenine dinucleotide NAD(P)H or NAD(P)+ [192]. However, no
studies have done to determine the role of this enzyme in F. tularensis during oxidative
stress. Altogether, these results indicate that AraC of F. tularensis displays a regulatory effect
on the structural components of RNA polymerase and gene products involved in the redox
reactions during oxidative stress.
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Figure 29. AraC-dependent transcription of regulatory proteins. (A) Gene expression
profile of regulatory genes within four operons of the ΔaraC mutant. (operons labeled by
blue boxes to the right). The Log2(fold change) values are indicated. Data presented are
cumulative of two independent experiments. (B) RNA polymerase Holoenzyme structure
modifed from Johnson Chavarria, E.M., 2016 [193]. The structure is composed of five
molecules and sigma factor to initiate RNA synthesis. Red circles indicate core subunits (β
and β’) encoded by rpoB and rpoC, respectively, and are downregulated by ΔaraC mutant
in response to oxidative stress.
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4.6.8. Transcriptional units differentially regulated by AraC of F. tularensis
Apart from regulating the RNA expression levels of genes encoded on operons, AraC
of F. tularensis exhibited a significant regulatory effect on a few transcriptional units during
oxidative stress. Figure 30 represents the differentially expressed genes in the ΔaraC
mutant as compared to the wild type F. tularensis LVS. The araC gene which is transcribed
as a single transcription unit remained downregulated to the greatest extent irrespective of
the treatment with menadione in the ΔaraC mutant. The pyrH gene that encodes uridylate
kinase enzyme to catalyze the synthesis of pyrimidine was also downregulated [194],
suggesting that AraC is involved in nucleotide damage repair in response to oxidative stress.
Another gene in the ΔaraC mutant that was largely affected by menadione treatment was
FTL_0426 coding for type I DNA topoisomerase. This enzyme is required for DNA
supercoil repair [195], indicating that AraC is also involved in the regulation of DNA repair
mechanisms in F. tularensis during oxidative stress. Furthermore, two genes FTL_0024 and
FTL_0031 were significantly upregulated in ΔaraC mutant compared to the wild type.
These genes encode serine/threonine transporter and acid phosphatase, respectively,
indicating that AraC negatively regulates genes required for transport of amino acids (serine
and threonine) during the conditions of oxidative stress. Additionally, since acid
phosphatase is essential for glucose and G6P phosphorylation and dephosphorylation
mechanisms in bacteria [196], AraC of F. tularensis is possibly involved in the negative
regulation of G6P to suppress the glucose metabolism and, thus, deactivate the TCA cycle.
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Figure 30. Transcriptional units differentially regulated by AraC of F. tularensis. Gene
expression profile displaying the genes transcribed as single transcription units that are
regulated by AraC. The Log2(fold change) values are indicated. The data represent the
average expression from two independent experiments.
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5. DISCUSSION
As a Tier 1 Select Agent, F. tularensis has a high infectivity rate and rapid onset of the
disease known as tularemia [19]. Many studies have devoted enormous efforts to understand
how F. tularensis avoids host defense mechanisms, replicates within an extremely secure
immune system, and eventually causes the deadly disease tularemia. Understanding virulence
mechanisms of F. tularensis is a fundamental approach that will certainly assist in decoding
the pathogenesis and navigating to the proper development of tularemia vaccine and
therapeutics. Furthermore, the ability of F. tularensis to survive the host bactericidal
mechanisms and replicate intracellularly is attributed to its unique regulation of virulence
genes. Gene regulation of F. tularensis virulence is complicated and is adaptable to the accurate
detection of environmental stimuli and host response to infection [137, 197]. Also, gene
regulation employs regulatory molecules and transcriptional regulators that dictate the
differential gene expression [197]. Transcriptional regulators are categorized based on their
structure, function, sequence conservation of DNA binding motifs, and amino acids alignment
[119, 197].
The AraC/XylS family is one of the largest families of bacterial transcriptional regulators
[139, 197]. Members of the AraC/XylS family can alter gene expression, mostly, positively
[119, 139, 197]. In rare cases, gene expression can be either negatively altered by members of
the family such as the CelD of Y. pestis [198], or both positively and negatively by the AraC
of E. coli and YbtA of Y. pestis [139, 199]. Transcriptional regulators are additionally classified
into two categories based on the regulation of their own transcription [139]. The first category
has signal receptors within the same protein that respond to the availability of substrates to
activate or repress genes expression [139]. Examples of this type of transcriptional regulators
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are AraC, XylS, RhaR, and UreR [139, 157, 200-202]. The second category requires the
activity of another regulator (activator or repressor) to control gene expression in a twocomponent regulatory system manner such as MarA, SoxS, and TcpN [120, 139, 203, 204].
The AraC/XylS family proteins operate three unique features, which are regulation of virulence
factors, stress response, and metabolism of carbons [139].
In the present study, we have characterized the role of a transcriptional regulator; AraC,
a member of the AraC/Xyls family, in intramacrophage survival and virulence of F. tularensis.
To date, no study has been conducted characterizing the regulatory role of AraC in Francisella.
Thus, the findings from this study are novel. Sequence alignment with previously characterized
AraC/XylS family proteins confirmed the presence of the unique HTH DNA binding domain
in the C-terminal residues of AraC. This signature DNA binding motif is conserved in all
members of the AraC/XylS family [139, 205]. The FTL_0689 gene encodes AraC of F.
tularensis LVS.
In this study, we considered several aspects for the investigation of the role of AraC
transcriptional regulator in tularemia pathogenesis. First, AraC is an extensively studied
transcriptional regulator in E. coli that is involved in the metabolism of L-arabinose [139, 197,
206]. Since L-arabinose metabolism has never been studied in F. tularensis, we considered
investigating this phenotype. Second, the araC gene of F.tularensis is located upstream of the
operon encoding Emr type MEP and transcribed in a divergent direction. Given the fact that
most AraC/XylS family regulators are transcribed divergently from their target gene or operon
[205], and since we have previously reported the involvement of MEP components, the emrA1
and silC, in F. tularensis virulence [87, 112], we hypothesized that araC of F. tularensis LVS
regulates the expression of the MEP components. Third, members of the AraC/XylS family
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such as AraC of E. coli and YbtA of Y. pestis had been reported to exert their regulation in cis
or in trans [139, 199], proposing a possibility for AraC to regulate F. tularensis genes in trans.
Given the rationales above, we hypothesized that AraC of F. tularensis is a unique
transcriptional regulator that plays an important role in tularemia pathogenesis. An AraC gene
deletion mutant was generated in this study and characterized phenotypically with regards to
L-arabinose utilization, sensitivity to oxidants, heavy metal ions, and antibiotics. Further, we
investigated the global gene regulation of AraC in F. tularensis LVS in response to oxidative
stress.
Results from sugar utilization experiments unveiled that AraC transcriptional regulator
is not involved in L-arabinose utilization as F. tularensis LVS is deficient for growth in the
presence of L-arabinose. It also highlighted that the availability of D-glucose is indispensable
for the growth of F. tularensis LVS and is the sugar source of choice. These findings
demonstrate that unlike the AraC transcriptional regulator of E. coli involved primarily in Larabinose metabolism, the AraC of F. tularensis LVS has a distinct function other than the
carbon metabolism.
The genomic organization of the Emr type multidrug efflux pump (MEP) of F. tularensis
is unique, composing of three adjacent genes emrB, emrA1, and silC that constitute an operon
[87, 112]. The transcription of the araC gene in the opposite direction of emrB, emrA1, and
silC genes suggested a possible involvement of AraC in the regulation of these MEP genes. A
similar genomic structure of MEP is present in Pseudomonas aeruginosa (P. aeruginosa) with
MexR transcriptional regulator transcribed divergently from the mexAB-oprM multidrug efflux
system [118]. In response to oxidative stress, MexR transcriptional regulator detaches from the
promotor and functions as an activator to initiate the MEP genes expression [118]. Moreover,

99

Campylobacter jejuni (C. jejuni) possesses a cmeGH multidrug efflux pump that is controlled
by Fur repressor transcribed divergently upstream of the operon [116]. Therefore, as a
transcriptional regulator, araC was hypothesized to control the expression of the components
of the MEP. This notion was investigated by using emrA1 mutant as a comparison tool
throughout this study and supported by results from qRT-PCR analysis that MEP components
are downregulated in the ΔaraC mutant in response to oxidative stress, suggesting a possible
role for AraC in MEP gene regulation.
Oxidant sensitivity testing was performed using peroxides and superoxide-generating
compounds. Results from peroxides sensitivity testing demonstrated that similarly to the
emrA1 mutant, the ΔaraC mutant is sensitive to increasing concentrations of H2O2.
Additionally, the ΔaraC mutant exhibited high sensitivity to organic peroxides as compared to
the wild type F. tularensis LVS. A similar phenotype has also been reported for the emrA1 and
silC mutants of F. tularensis LVS [87, 112]. On the other hand, results from the sensitivity
testing of superoxide-generating compounds revealed an enhanced sensitivity of the ΔaraC
mutant towards pyrogallol but not against paraquat or menadione. Studies on emrA1 and silC
mutants have demonstrated a high sensitivity to these superoxide-generating compounds [87,
112].
The selective sensitivity of ΔaraC mutant to one superoxide-generating compound but
not to others can be attributed to the mechanism of action of each compound. Paraquat is a
redox cycling compound that disrupts the electron transport channel in the bacterial cell
membrane by inhibiting the reduction of NADP to NADPH during the redox reactions
resulting in the production of highly microbicidal reactive oxygen species (ROS) such as
superoxide anion, singlet oxygen, hydroxyl, and peroxyl radicals [207, 208]. Menadione is a
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redox-cycling compound that induces oxidative stress in bacteria by acting first as
aminoglycoside to disrupt the cell wall and plasma membrane [209] and then transporting into
the bacterial cell where it converts molecular oxygen into superoxide radicals and H 2O2 as a
result of reduction by redox enzymes [210]. Both the compounds act by disrupting the bacterial
plasma membrane to induce the production of ROS. However, several factors can induce the
resistance of ΔaraC mutant to both paraquat and menadione. One of them is the presence of
the outer membrane that inhibits the permeability of these superoxide-generating compounds
into the cytoplasmic membrane of the bacteria [211]. In addition, F. tularensis produces the
antioxidant enzymes, SodB and SodC, that maintain the redox homeostasis and hinder the
production of ROS [30]. Since ΔaraC mutant did not exhibit enhanced sensitivity toward
paraquat and menadione, we perceived that the production of the antioxidant enzymes is not
disrupted by the araC gene deletion. Secretion of SodB and KatG enzymes is impaired in the
emrA1 mutant [87, 112]. Thus, AraC due to its impact on the expression of the MEP genes
may lower the secretion of these antioxidant enzymes but may not completely abolish it and
therefore mirror the phenotype of the emrA1 mutant.
Furthermore, pyrogallol, a polyphenolic compound with an antibacterial effect reported
on a wide range of Gram-negative as well as Gram-positive bacteria [212-215]. Pyrogallol is
a type of catechins that kills bacteria by interaction with the cytoplasmic membrane, resulting
in disruption of membrane permeability [215, 216]. In a study conducted on epigallocatechin
gallate mechanism of action on Bacillus subtilis demonstrated that this compound attaches to
and disrupts the outer membrane proteins, including transport systems of the bacteria, and then
generates H2O2 and cerium [216] that consequently leads to ROS production. Another study
also demonstrated that epigallocatechin gallate attaches to the porin protein in the outer
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membrane of E. coli to diminish its activity [217]. The sensitivity of ΔaraC mutant to
pyrogallol as compared to the wild type suggests that ΔaraC mutant may have encountered
membrane protein damage. We speculate that AraC may be important for maintaining
membrane integrity of F. tularensis through the regulation of genes involved in this function.
Since the emrA1 and silC mutants exhibited extreme sensitivity to pyrogallol [87, 112], and
as we indicated previously that members of the AraC XylS family function in a two-component
regulatory manner [139], we proposed that AraC may participate in MEP components
regulation.
The results from this study demonstrated that AraC of F. tularensis is not involved in
resistance to heavy metals. Similar to the wild type F. tularensis LVS, ΔaraC mutant was not
sensitive to treatment with silver nitrate. Resistance to silver compounds had been proposed to
be inherited among different Francisella species [87]. Silver nanoparticles used as an
antibacterial cure for various fish infections are not effective in treating cases of Francisella
noatunensis [218]. In contrary to ΔaraC mutant, studies on heavy metals sensitivity unveiled
that emrA1 and silC mutants are extensively sensitive to silver compounds [87, 112]. This
indicated that MEP components of F. tularensis are required for heavy metal resistance but
AraC does not contribute to this resistnace.
Furthermore, the results from this study revealed that AraC of F. tularensis is not
involved in antibiotic resistance. Antibiotic susceptibility testing against various classes of
antibiotics unveiled that ΔaraC mutant is identical to the wild type F. tularensis LVS in
antibiotic sensitivity. In contrary, EmrA1 and SilC together were reported to be responsible
for the effusion of some antibiotic subsets including streptomycin, nalidixic acid, and
chloramphenicol [87]. Additionally, transcriptional regulators of other bacterial species
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including AarP (Providencia stuartii), MarA and Rob (E. coli), and RamA (Klebsiella
pneumoniae) are involved in regulation in regards to antibiotics, organic compounds, and
heavy metals stressors [139, 219, 220]. Altogether, we concluded that AraC transcriptional
regulator of F. tularensis does not directly contribute to the regulation of MEP genes.
Phenotypic characterization of ΔaraC mutant suggested that AraC transcriptional
regulator of F. tularensis may be involved in the regulation of the oxidative stress response.
Therefore, investigation of the global regulatory role of AraC of F. tularensis was performed
to obtain novel understanding about its role in response to oxidants. The results from whole
transcriptome data analysis in the absence of oxidant stressor revealed that despite the loss of
araC gene in the mutant, the transcription profiles of both the ΔaraC mutant and the wild type
F. tularensis LVS were identical. These results demonstrated that AraC transcriptional
regulator of F. tularensis does not exert its regulatory role when bacteria are growing in rich
homeostatic growth conditions. These results also suggested that AraC gets activated only
when the bacteria are exposed to certain stress conditions. Since the ΔaraC mutant exhibited
sensitivity towards oxidants, our primary hypothesis was that AraC plays a regulatory role
under the conditions of oxidative stress. SoxS, an AraC/XylS family transcriptional regulator
of E. coli is induced by oxidative compounds including paraquat and menadione to activate
the transcription of the SoxRS regulon [120, 139, 204].
Our results demonstrate that activation of the AraC transcriptional regulator of F.
tularensis in response to oxidative stress induced by menadione resulted in the differential
expression of a multitude of genes some of which are transcriptional units and/or cotranscribed as operons. These genes are involved in key pathways that contribute to tularemia
pathogenesis. Whole transcriptome analysis of bacteria treated with menadione confirmed the
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notion that AraC transcriptional regulator requires to be induced by a stressor to employ its
regulation. The results from this study unveiled the involvement of AraC in the positive
regulation of some FPI genes in response to oxidative stress. Components of the FPI were
determined to constitute a Type VI secretion system of F. tularensis [221]. We demonstrated
that ΔaraC mutant treated with menadione exhibited a significant downregulation of a subset
of FPI genes. Thus far, several studies have published the fundamental role of FPI genes in
intramacrophage replication and/or Francisella virulence [102, 222-225]. In F. novicida, iglJ,
iglI, and iglG were found to be crucial for Type VI secretion system assembly [226]. We
observed that iglJ and iglI genes were significantly downregulated in ΔaraC mutant following
menadione treatment, indicating that type VI secretion system assembly may be impaired in
the mutant. The FPI genes iglJ, iglI, or iglG however, have been reported to be indispensable
for intramacrophage replication and, specifically, the phagosomal escape [226].
Our results demonstrated the downregulation of dotU gene in the ΔaraC mutant. DotU
is one of the Type VI secretion system core proteins [170]. In Legionella pneumophila, IcmFDotU homologs are required for Type IV secretion system stability but not for its functionality
[227]. However, DotU is crucial for type VI secretion system functionality in F. tularensis
[170]. DotU protein is implicated in the secretion of other FPI proteins: Hcp and VgrG of
Vibrio cholerae and P. aeruginosa [101]. In F. tularensis, DotU is an essential virulence factor
required for intracellular growth and virulence in mice [170]. Furthermore, the results
exhibited a significant reduction in pdpC gene expression of ΔaraC mutant in response to the
oxidant. While PdpC in conjugation with PdPD were found to be partially involved in
intramacrophage growth of F. novicida and Schu S4, they are extensively required for the
complete virulence in vivo [228, 229].
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The results also revealed the downregulation of pdpE and Hcp genes in ΔaraC mutant
after exposure to menadione. It was reported that PdpE structure and full functionality is
affected by pdpC gene integrity [228]. A defect in pdpC gene results in the transcription of a
disrupted PdpE protein. Similarly, the downregulation of pdpE gene in ΔaraC mutant can be
caused either by exposure to menadione or due to the downregulation of the pdpC gene.
Another study also published the possibility of the presence of a sec secretion signals in PdpE
due to its ability to translocate into the outer membrane of Francisella [170]. In an attempt to
define the role of PdpE in F. tularensis, it was demonstrated that PdpE protein sequence
exhibited poor homology with the Hcp protein. However, both proteins were found to perform
distinct functions [170]. While pdpE is dispensable for type VI secretion system assembly,
phagosomal escape, or virulence in mice in both of the F. novicida [226] and F. tularensis LVS
[230], its role is yet to be determined. The Hcp protein, on the other hand, is one of type VI
secretion system major structural proteins [231]. It forms a tube-like channel in F. tualrensis
that is in conjunction with VipA and VipB sheathing to facilitate the translocation of a principle
virulence protein, VgrG, effector domain into its target location [170]. The downregulated
gene expression profile of the FPI genes in the ΔaraC mutant, also corroborates with attanuated
intramacrophage survival and virulence of F. tularensis in mice in a dose-dependent manner.
Besides the FPI encoded genes, the whole transcriptome analysis of the ΔaraC mutant
under oxidative stress also revealed the involvement of AraC of F. tularensis LVS in the
regulation of two genes, aroA, and rnhA, that are a part of heat stress related operon. The role
of AroA in Francisella is not determined yet. However, in Salmonella, AroA is involved in
the shikimate pathway that catalyzes the synthesis of aromatic amino acids from glucose [232].
Attenuation of the aroA gene, commonly used to study metabolic pathways, results in
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accumulation of pyruvate within the bacteria and consequently cause osmotic pressure [233].
Therefore, AroA is essential to maintain bacterial homeostasis through the shikimate pathway.
In addition, it was reported that aroA gene deletion of Salmonella resulted in aromatic amino
acids auxotrophy and attenuation of virulence [232]. In agreement with the role of AroA in
Salmonella, oxidative stress resulted in the downregulation of aroA gene in the ΔaraC mutant
that can further explain the attenuation of intramacrophage growth and virulence in mice.
AraC of F. tularensis positively regulated the rnhA gene that encodes ribonuclease H. In
many Gram-negative bacteria such as Yersinia, Salmonella, Helicobacter pylori (H. pylori),
and Shigella flexneri, ribonucleases are known to function as virulent factors [234]. A study
reported that RnhA contributes to Mycobacterium smegmatis (M. smegmatis) defense against
the destruction by oxidative stress [172]. In the same study, it was reported that deletion of
rnhA gene has no impact on the bacterial viability [172]. Interestingly, deletion of both rnhA
and rnhB genes in M. smegmatis enhanced bacterial sensitivity to H2O2 [172], which explains
the sensitivity of the ΔaraC mutant to H2O2 observed in this study. Other studies also
demonstrated that rnhA in conjugation with rnhB and rnhC genes are required for B. subtilis
viability [173]. Therefore, we propose that AraC by regulating the epression of rnhA gene
protects F. tularensis against oxidative stress.
In addition, we have observed that the expression level of rpoH gene was not altered in
ΔaraC mutant in response to oxidative stress and remained downregulated. However, results
from qRT-PCR unveiled the significant upregulation of heat shock proteins (GroEL, DnaK,
DnaJ, and Hsp 40) in the ΔaraC mutant after menadione treatment. In E. coli, GroES and
GroEL proteins were discovered to be induced in response to various stressors including heat
shock, oxidative stress, nutrient deprivation, and SOS [235]. Additionally, DnaK protein was
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also detected when exposing bacteria to peroxides, UV radiation, nutrient deprivation, and
some antimicrobial agents [235]. Similarly, a study on F. tularensis reported that RpoH is
required for the positive regulation of heat shock proteins when bacteria are under different
stress conditions including high temperature or oxidative stress [149]. Therefore, although heat
shock proteins are mostly induced in response to high-temperature stress, other stressors also
promote their induction. We confirmed this notion as well as the role of AraC in regulating
heat shock genes by conducting a thermal resistance experiment. The result demonstrated that
in the physiologic temperature, the growth of ΔaraC mutant is similar to the wild type strain.
However, when growing the bacteria in extremely high temperature, the ΔaraC mutant
exhibited significantly enhanced viability as compared to the wild type F. tularensis LVS. The
viability of the transcomplemented strain was significantly higher than both the ΔaraC mutant
and the wild type F. tularensis LVS the due to the presence of the GroEL promotor in the
transcomplementation vector that governs the expression of araC. These findings support our
qRT-PCR results and demonstrate that AraC is required for the regulation of heat shock
proteins in F. tularensis in response to heat and oxidative stresses.
The results from whole transcriptome analysis further highlighted the involvement of
AraC of F. tularensis LVS in the positive regulation of F1F0 ATP synthases in response to
oxidative stress. Treatment with menadione induced the significant downregulation of the
ATPase subunits in ΔaraC mutant as compared to the wild type F. tularensis LVS. ATPases
are known for their role in the generation of the electrochemical gradient to facilitate the
penetration of protons, ions, and metabolic molecules through cell membrane [236, 237].
ATPases are required by pathogens to tolerate acidic environments. In Streptococcus mutans,
ATPase gene is upregulated when the bacteria is under acidic pH stress [238]. Additionally,
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ATPases are crucial for energy conveyance in several pathogens. ATPases catalyze the
conversion of ADP and inorganic phosphate into ATP [239]. Few studies have also reported
the response of the ATPases during oxidative stress. In E. coli, YchF protein has an ATPase
activity that is sensitive to H2O2 exposure. It was reported that OxyR transcriptional regulator
causes the downregulation of ychF in response to oxidative stress [240]. The downregulation
of ATPases in the ΔaraC mutant in response to oxidative stress indicates that AraC stimulates
ATPases to support oxidant resistance. The results allow us to speculate that oxidative stress
inhibits energy production in the ΔaraC mutant, and consequently impeds other vital
mechanisms.
The results from this study further demonstrated the engagement of AraC in the
regulation of the TCA cycle in F. tularensis during oxidative stress. Several studies have linked
the TCA cycle with the virulence of F. tularensis during stress conditions [187, 188, 241, 242].
We observed the downregulated gene expression of key TCA cycle enzymes in the ΔaraC
mutant after menadione treatment. The operon encoding pyruvate dehydrogenase enzyme was
significantly downregulated. The pyruvate dehydrogenase is an enzyme that catalyzes the
synthesis of the first enzyme, Acetyl-CoA, of the TCA cycle [180]. It has three subunits: E1:
pyruvate dehydrogenase (AceE), E2: dihydrolipoamide transacetylase (AceF), and E3:
dihydrolipoamide dehydrogenase (Lpd) [188]. We also observed downregulation of another
enzyme, oxoglutarate dehydrogenase, encoded on another operon. The oxoglutarate
dehydrogenase promotes the conversion of α-ketoglutarate (or 2-oxoglutarate) into succinylCoA in the TCA cycle. Oxoglutarate dehydrogenase is also composed of three subunits: E1:
2-oxoglutarate dehydrogenase (SucA), E2: dihydrolipoamide succinyltransferase (SucB), and
E3: lipoamide dehydrogenase (Lpd) [188]. In F. novicida, a study had shown the requirement
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of the E1(AceE) subunit of the pyruvate dehydrogenase enzyme in intramacrophage growth
[243]. In addition, another study have demonstrated the contribution of E3 (Lpd) subunit to F.
tularensis LVS virulence [148]. Other than its major role in metabolism, the E3 (Lpd) subunit
is a component of M. tuberculosis defense mechanism against oxidative stress [244].
Furthermore, double deletion of sucA and suB genes in S. Typhimurium attenuated the bacteria
for virulence in mice [245]. In accordance with the results from studies explained above,
exposing AraC deficient bacteria to the oxidant repressed the expression of all three subunits
both pyruvate dehydrogenase and oxoglutarate dehydrogenase. Moreover, we have observed
that ΔaraC mutant is attenuated for intramacrophage growth and virulence in mice. Therefore,
it appears that regulation of the TCA cycle of F. tularensis LVS by AraC is also associated
with intramacrophage survival and virulence especially when the bacteria are experiencing an
oxidative stress environment.
The results from whole transcriptome analysis denoted that AraC regulates the
pantothenate metabolism in F. tularensis. The pantothenate, also known as vitamin B5, is an
essential metabolic molecule that is a central component of the CoA of the TCA cycle [182].
In E.coli and S. Typhimurium, the de novo synthesis of pantothenate molecule relies on their
ketopantoate reductase genes [246]. In contrast, F. tularensis virulent Schu S4 strain lacks
these genes, but still synthesizes the pantothenate molecule [182]. F. tularensis LVS, on the
other hand, harbors the ketopantoate reductase genes and loss of any of these genes renders the
bacteria auxotrophic for pantothenate [182]. The ketopantoate reductase genes in F. tularensis
are composed of a group of five genes (coaX, panD, panC, panB, and panG) that promote the
enzymatic reaction of pantothenate synthesis. F. novicida requires the coaX gene for the
successful dissemination into mice organs [247].
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Moreover, a striking increase in the

expression level of F. tularensis ketopantoate reductase genes post-invasion of bone marrowderived macrophages has been reported [160]. Similarly, lack of both PanC and PanD in
attenuates the virulence of M. tuberculosis in mice [248]. These studies established the
significance of pantothenate for F. tularensis in vivo and in vitro intracellular life cycles. Our
analysis indicated that all of the five ketopantoate reductase genes were significantly
downregulated after exposing the ΔaraC mutant to menadione. Therefore, we infer from these
observations that during oxidative stress, F. tularensis employs the AraC transcriptional
regulator to synthesize the pantothenate that consequently contributes to the formation of CoA
enzyme. The acetylation of CoA enzyme then initiates the TCA cycle.
Our observations further indicate that AraC is also involved in the positive regulation of
glucose metabolism in F. tularensis LVS. Three genes pgk, pyk, and fba were significantly
downregulated in the ΔaraC mutant after menadione treatment. PGK (phosphoglycerate
kinase) is an essential enzyme for the breakdown of glucose into pyruvate and subsequently,
the release of high energy [185]. Correlation between phosphoglycerate kinase and bacterial
virulence has not been completely established. However, it has been reported that PGK is
required for Corynebacterium glutamicum (C. glutamicum) growth as bacteria with the pgk
gene deletion is deficient for glucose metabolism [249]. Furthermore, deletion of the pyruvate
kinase encoding gene (pyk) in C. glutamicum resulted in a growth defect even in the culture
media supplemented with glucose [250]. In contrast, in this study, it was observed that both
the pgk and pyk genes were downregulated in the ΔaraC mutant but the growth rate of the
ΔaraC mutant remained similar to the wild type F. tularensis LVS when grown in CDM
supplemented with D-glucose (Figure 14C). In Enterococcus faecalis, PYK activation is
promoted by fructose 1,6-bisphosphate (FBP) [186], which is then metabolized by the enzyme
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fructose-bisphosphate aldolase class II (FBA). The FBA is indispensable for the viability
during acute and chronic stages of several bacterial pathogens including M. tuberculosis [251].
Several efforts to disrupting the fba gene in E. coli, B. subtilis, and P. aeruginosa have failed
[187]. Moreover, in addition to the bacterial pathogens, Toxoplasma gondii, an intracellular
parasite, requires the fba gene for survival, multiplication, and pathogenesis [252]. A study has
shown that the FBA plays an important role in Francisella cytosolic replication only if
gluconeogenesis substrate is available but is not required required for the bacterial escape from
the phagosome [187]. Additionally, deletion of fba gene in Francisella induces the expression
of the antioxidant enzyme KatG [187]. Since OxyR regulates the expression of katG [156], it
has been proposed that fba serves as a secondary regulator for katG [187]. In the present study,
the expression of katG gene was not affected by araC deletion. Therefore, we suggest that
AraC positively regulates the gluconeogenesis and glycolysis pathways in F. tularensis to
enhance the cytosolic replication. Further, as the end product of glucose metabolism is
pyruvate, which is a key molecule in initiating the TCA cycle, AraC may contribute to the
regulation of the TCA cycle indirectly through the carbon metabolism.
We have also noted the involvement of AraC in the positive regulation of tpiA gene
encoding triosephosphate isomerase, an enzyme required for glucose metabolism and TCA
cycle. Bacterial glycolytic enzymes are different than those of the eukaryotes in their
involvement in pathogenesis [253, 254]. In Staphylococcus aureus, Lactobacillus plantarum,
and Paracoccidioides brasiliensis, TPI is essential for attachment to host cells in addition to
its function in glycolysis [156]. In M. tuberculosis, tpi is required for intracellular growth
[255]. Deletion of tpi in M. tuberculosis attenuates the bacterial virulence in vivo [255].
Conversely, TPI in other bacteria, including E. coli and S. Typhimurium, is involved in, but
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not required for pathogenesis [256]. Consistent with these observations, it appears that AraCmediated regulation of TPI may contribute to the virulence of F. tularensis.
The RNA-seq data analysis also demonstrated the downregulation of an additional gene
(glmM) in menadione treated ΔaraC mutant that is involved in glucose metabolism. The glmM
gene encodes for phosphoglucosamine mutase enzyme that catalyzes the conversion of
glucosamine-6-phosphate into glucosamine-1-phosphate in the cytosol [257]. The end product
of this reaction is essential for the synthesis of bacterial peptidoglycan [258]. In addition,
GlmM enzyme is essential for virulence of Gram-positive bacteria. However, several reports
demonstrated that the GlmM enzyme is required for the survival of most Gram-negative
bacteria including E. coli, S. Typhimurium, P. aeruginosa, and H. pylori [259-261]. Similarly,
the downregulation of glmM in the ΔaraC mutant during oxidative stress further explains the
attenuation of virulence of the ΔaraC mutant. Furthermore, the defect in glucose metabolism
due to the downregulation of GlmM can also cause a subsequent shortening of the TCA cycle
and reduce bacterial fitness in response to oxidative stress. Energy production impeded by the
glucose metabolism defect thus may cause the ΔaraC mutant to become less viable
intracellularly than the wild type F. tularensis LVS. Although not investigated in this study,
the downregulation the glmM may also result in a defect in the ΔaraC mutant peptidoglycan
layer and thus may affect the bacterial integrity and permeability and increase susceptibility to
oxidants.
The results from the whole transcriptome analysis of the ΔaraC mutant also revealed the
downregulation of adenine phosphoribosyltransferase encoding gene (apt) after treatment with
menadione. The adenine phosphoribosyltransferase catalyzes the conversion of free adenine
into AMP [262], which can further be utilized for the interconversion into ADP and/or ATP.
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AMP also contributes to the synthesis of the acetyl-CoA, the central enzyme in the TCA cycle
[263]. Furthermore, AMP is a key constituent of the RNA [263]. Additional genes that were
downregulated within the same metabolic operon included secG, encoding the SecG translocon
subunit, as well as Succinate dehydrogenase encoding genes (sdhA, sdhB, sdhC, sdhD).
Collectively, these results indicate that AraC may play an essential role in F. tularensis
pathogenesis by positively regulating the AMP synthesis thereby promoting the TCA cycle.
The results from this study further informed that AraC of F. tularensis also controls the
expression of antiporters and regulatory proteins. One of these genes encodes an amino acid
antiporter. This antiporter is an arginine (ArgP) transporter. Attenuation of ArgP results in a
delayed phagosomal escape and defect in cytosolic replication [264]. A study has established
that this arginine transporter in F. novicida and F. tularensis LVS support metabolic pathways
during intracellular invasion [264, 265], highlighting the significance of arginine for
Francisella pathogenesis. Furthermore, it was also determined that deficiency in arginine
acquisition caused a defect in the production of ribosomal proteins [264]. Suppression of the
synthesis of ribosomal proteins is commonly observed in organisms exposed to various stress
conditions [264]. Therefore, arginine plays a crucial role in promoting the phagosomal escape
and enhancing intracellular replication. In agreement with the literature, exposing ΔaraC
mutant to oxidative stress resulted in the downregulation of argP, thus, may limit the arginine
acquisition and defective protein synthesis ultimately resulting in attenuation of
intramacrophage growth.
The results from this study additionally revealed that AraC positively regulates the
expression of other regulatory genes, rpoB, and rpoC. These genes encode two key
components, the β (RpoB) and β’ (RpoC) that constitutes the catalytic core of RNA polymerase
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[266]. RpoB and RpoC were both downregulated in the ΔaraC mutant after menadione
treatment, indicating inhibition of protein synthesis, thus reducing the viability intracellularly
than the wild type bacteria. The downregulation of the rpoB and rpoC in conjunction with
downregulation of argP further indicate the suppression of protein synthesis in the ΔaraC
mutant. Furthermore, the NAD(P)/FAD-dependent oxidoreductase encoding gene was
upregulated in the ΔaraC mutant in response to oxidative stress. This enzyme catalyzes the
redox reactions NAD(P)H or NAD(P)+. The induction of NAD(P)H or NAD(P)+ indicates a
defect in the electron transport chain homeostasis, which subsequently reduces the bacterial
viability.
In addition to the role of AraC in regulating operons, the results from whole
transcriptome analysis revealed the involvement of AraC in regulating genes transcribed as
single transcriptional units. Data analysis demonstrated that type I DNA topoisomerase was
downregulated in the ΔaraC mutant when treated by menadione. Inhibition of topoisomerase
I had been exploited as a target for therapeutics in several organisms including E. coli, Y. pestis,
and Streptococcus pneumoniae [267, 268], indicating its importance in pathogenesis. F.
tularensis requires the activity of topoisomerase I to repair DNA damages and supercoils
exerted by exposing to the oxidative agents. Our results demonstrate that AraC negatively
regulates Topoisomerase I when F. tularensis is exposed to oxidative stress.
Furthermore, the data analysis indicated that AraC of F. tularensis also negatively
regulates pyrH gene that encodes the uridylate (UMP) kinase enzyme. E. coli utilizes the UMP
kinase to establish de novo pyrimidine nucleotides synthesis [269], providing evidence of the
importance of the pyrH gene. Similarly, F. tularensis employ the UMP kinase to compensate
for nucleotides damage as a result of oxidative stress.
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Lastly, the results from this study revealed the involvement of AraC in the negative
regulation of two genes of F. tularensis. One of these genes encodes serine/threonine
transporter. These results indicate that along with arginine transporter, additional amino acid
transporters such as serine/threonine transporter are also under the control of AraC. Legionella
pneumophila harbors MFS threonine transporter, which contributes to the intracellular
bacterial replication [270]. Both Francisella and Legionella mostly rely on amino acids as the
main carbon [271]. It was observed that exposing ΔaraC mutant to oxidative stress
significantly upregulated serine/threonine transporter gene indicating that in response to
oxidative stress, AraC of F. tularensis restricts the amino acid uptake and relies on arginine to
conserve energy. Moreover, the induction of the serine/threonine transporter in ΔaraC mutant
also indicates that mutant is hunting for every nutritional source to maintain its viability.
The other gene that is negatively regulated by AraC in regards to oxidative stress is the
one encoding acid phosphatase. Acid phosphatase is an enzyme that catalyzes inorganic
phosphates mobility [272]. It is also engaged in the eukaryotic and prokaryotic phosphor-relay
system [272]. Acid phosphatase is required by Francisella strains for intramacrophage growth
[273, 274]. However, the virulent strains (type A and B) strains do not employ acid
phosphatases to overcome intracellular oxidative burst [274]. F. tularensis virulent strains rely
on fevR to overcome NADPH oxidase [274]. There are at least five acid phosphatases identified
in Francisella [272], which are encoded by distinct genes than the one induced in our analysis.
The gene encoding acid phosphatase was significantly upregulated in ΔaraC mutant after
treatment with menadione, indicating that this gene may not involved in virulence of the wild
type.
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Collectively, the results obtained from the present study demonstrate that AraC
transcriptional regulator exerts a global regulatory role on several key pathways of F.
tularensis LVS. We determined that AraC regulates FPI genes and contributes to the in vivo
and in vitro virulence of the F. tularensis LVS strain. We also unraveled the regulatory role of
the AraC in heat shock proteins in response to oxidants and heat stress. Additionally, AraC
plays an important role in regulating F. tularensis LVS metabolic pathways, specifically the
TCA cycle, by targeting key enzymes that are indispensable for the cycle. We further observed
the engagement of the AraC in the regulation of DNA repair pathways as well as controlling
protein synthesis of F. tularensis during oxidative stress. Altogether, we conclude that AraC
belonging to the AraC/XylS family of transcription regulator plays an essential role in
oxidative stress response of F. tularensis LVS.
Significance of the study and future directions
This study provides a wide range of knowledge about F. tularensis LVS response to
oxidative stress from the point view of gene regulation. It provides a powerful tool for
tularemia therapeutic applications. Up until now, efforts have been focused on developing
effective tularemia treatment with little success. The present study characterized a global
transcription regulator that controls several pathways in F. tularensis LVS and thus, can be
utilized as an effective target to develop effective tularemia therapeutics.
In the future, we aim to determine the exact mechanism of AraC-dependent regulation
of these virulence and metabolic pathways by identifying binding domains in the promoter
regions of the regulated genes/operons by chromatin immunoprecipitation (ChIP) sequencing
and electrophoretic mobility shift (EMSA) assays.
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